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Toxocara can is (T. canis) is the common round worm of dogs and other Canidae. 
Seroprevalence surveys suggest that human infection with this parasite is second only the 
pinworrn in developed countries. 
ii 
Human infection with T. canis is difficult to demonstrate because infecting larvae remain 
developmentally arrested within the tissues. The current diagnosis of toxocariasis is based 
on clinical findings correlated with the detection of specific antibodies in the serum. 
However, many seroresponders show no evidence of clinical infection which questions the 
relevance of detecting an antibody response to T. canis in these people. 
A positive test (theoretically) shows exposure to T. canis but doesn't indicate the 
recentness or severity of the event. The enigmatic finding of high levels of seropositivity 
within New Zealand emphasises the need for a definitive assay for the diagnosis of 
current T. canis infection. This should be able to not only detect true seroresponders, but 
also differentiate past from current infection. 
T. canis larvae are known to release excretory-secretory antigens in vivo and in vitro. The 
detection of these antigens in serum potentially provides a marker for current infection. 
a 
The aim of this research was the development and evaluation of an ELISA capable of 
detecting circulating ES antigens in human serum. 
Four assays for ES antigen detection were evaluated using both polyclonal antisera 
produced against T. canis and a T. canis-specific monoclonal antibody. 
iii 
A Sandwich ELISA was abandoned because of unacceptable levels of cross-reactivity 
between the two different polyclonal antisera used in the assay. A Competitive Inhibition 
ELISA compared well with overseas studies in terms of measuring in vitro produced ES 
antigens added to normal human sera. However, this assay was unable to detect 
circulating ES antigens in any of the test sera examined. It could not be ascertained if this 
was because the levels of antigen present were below the level of sensitivity of the assay. 
Alternatively, the inability to detect circulating ES antigens by this assay may be linked to 
heat !ability of the antigens following the EDTA/heat treatment used to dissociate any 
immune complexes present, although the literature would suggest otherwise. 
The two monoclonal antibody-based antigen assays investigated revealed a difference in 
sensitivity of an order of magnitude, despite the use of the same monoclonal antibody to 
detect the ES antigens. The more sensitive assay of the two appeared to allow the 
detection of un-complexed circulating ES antigens in a number of test sera. 
However, both the Competitive Inhibition ELISA and the monoclonal antibody-based 
ELISA seemed capable of detecting a heat-labile epitope present in a number of sera, 
resulting in the apparent recovery of low levels of un-complexed ES antigens. EDT A/heat 
treatment to recover total ES antigens present abrogated this signal. Evaluation of the 
monoclonal antibodies raised against ES antigens may increase the specificity of this assay 
when assaying human sera. 
iv 
The inability to detect total ES antigens in a number of test sera when using the 
Competitive Inhibition ELISA supports the view that the level of circulating ES antigens in 
many infected individuals may prove to be too low to be detected in such an assay and 
may necessitate the development of an alternative approach to detecting current infection. 
KEY WORDS: Toxocara canis; ES antigens; antibody; ELISA; humans; diagnostic 
assay; current infection 
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Chapter 1 
Introduction 
A large percentage of the world's millions of domestic dogs are infected with Toxocara 
canis, the common roundworm of Canidae (Glickman & Schantz, 1981). Seroprevalence 
surveys suggest that human infection with this parasite is also common worldwide and 
may be second only to pinworm infections amongst the helminth infections in developed 
countries (Schantz, 1989). This is the result of many factors including high levels of pet 
ownership, high prevalence of T. canis infection in dogs and the longevity of infective T. 
canis eggs in the environment (Glickman & Schantz, 1981; Parsons, 1987; Barriga, 1988). 
1 
Infection with T. canis poses a poorly defined health hazard to humans. The difficulties in 
demonstrating the presence of larvae within tissues makes diagnosing human infection a 
challenge. The current diagnosis of toxocariasis is based on clinical findings, correlated 
with the detection of specific antibodies in the serum, detected by an enzyme-linked 
immunosorbent assay (ELISA). While two well documented syndromes are attributed to 
migrating T. canis larvae within the tissues of the body, seroprevalence surveys suggest 
that many human infections are subclinical (Glickman et al. 1987; Taylor et al. 1988; 
Caucanas et al. 1988). 
Seroepidemiological studies in developed countries (including New Zealand) have found 
between 2% and 7% seropositivity in presumably healthy populations (de Savigny et al. 
1977; Van Knapen et al. 1983; Nicholas et al. 1986; Barriga, 1988; Williamson et al. 1988; 
Lungstrom & Van Knapen, 1989). 
Within New Zealand, serologic studies have highlighted several populations with a higher 
seropositivity than anticipated (Williamson et al. 1988). These include "at risk" groups 
such as rural people (7%), hydatid control officers (27.4%) and dog breeders (13.9%). 
These seroprevalences reflect those found in studies of similar groups in the United 
Kingdom (Woodruff, 1978). It is possible that repeated exposure to T. canis infection may 
be reflected in a sustained or increased humeral response, not necessarily related to 
increased larval burden within these people. High levels of enigmatic seropositivity were 
also found in rural Maori children (83%), post-partum mothers (33%) and myalgic 
encephamyelitis (M.E.) sufferers (25%) (Williamson et al. 1988). These results are 
significantly different from the 3% to 7% seropositivity previously determined for the 
normal urban/rural population (Clemett et al. 1987). 
2 
The high seropositivity amongst Maori children is arguably attributable to ethnic, 
environmental and socio-economic differences, similar to those found by Hermann et al. 
(1985) in the United States of America. This is supported by the higher than anticipated 
levels of seropositivity (44%) amongst age-matched (9 to 12 years) European children from 
the same rural area. However these results are at variance with the 3.1 % seropositivity 
found in rural blood donors (aged between 16 to 19 years) from Canterbury. Two factors 
are emerging which may also contribute to the high levels of seropositivity. High levels of 
infection with hepatitis B have been reported within this group Milne et al. 1985) and, 
more recently, endemic giardiasis has also been found within the Bay of Plenty (Okell & 
Wright, 1990). Lynch et al. (1988a) reported a reduced reaction to ES antigens in sera first 
adsorbed against antigens from Giardia sp. It is possible that a humeral response to either 
of these agents is generating a false positive seroresponse for T. canis. 
The high levels of enigmatic seropositivity found in the post-partum mothers may 
represent a stimulated response to T. canis . Hormonal changes during pregnancy are 
known to stimulate quiescent larvae in the tissues to migrate, resulting in prenatal 
infection in dogs (Webster, 1958; Scothorn et al. 1965; Burke & Robertson, 1985) and mice 
...... 
3 
(Dunsmore et al. 1983). There is also one documented case which may support a theory of 
vertical transmission in humans (de Savigny & Tizzard, 1977). 
Myalgic encephalomyelitis is a syndrome of chronic disability after (presumed) viral 
infection, thought to arise as a result of an impaired immune response (Murdoch, 1988). 
Animals with an impaired immune response have been shown to sequester increased 
numbers of T. canis larvae in the brain (Kayes & Oaks, 1980; Sugane & Oshima, 1982). T. 
canis larvae have also been implicated in the transport of viruses to the brain (Sprent, 
1955a; Gupta & Parvi, 1987). Muscle fatigability is the dominant and most persistent 
feature of ME (Ramsay, 1986). This symptom was also well documented in the cases of 
covert toxocariasis diagnosed in adults by Glickman et al. (1987). High levels of 
seropositivity within this group could therefore reflect current infection. 
Many questions remain unanswered about the relevance of positive ELISA test results for 
T. canis. While a positive test (theoretically) shows past or present infection with T. canis, 
it does not indicate the recentness or severity of the event (Clemett et al. 1986). Antibody 
titres have been reported to fall over time in people not exposed to reinfection. This raises 
the question of high antibody titres in the two groups of adults surveyed (i.e. 
post-partum mothers and M.E. patients). Why is seropositivity (and hence supposedly 
infection) so high in these groups when the background infection level is 3 - 7% (Clemett 
et al. 1987). The majority of these people would not be unduly environmentally or 
occupationally exposed compared with Hydatid Control Officers which suggests that the 
ELISA for determining seropositivity may be at fault. 
This speculation emphasises the need for a definitive assay for the diagnosis of T. canis 
infection. This assay must have the ability to not only detect true seroresponders, but also 
to differentiate current from past infection . 
...... 
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T. canis larvae are known to release excretory-secretory (ES) antigens in vivo and in vitro 
(Parsons et al. 1986). The detection of these antigens in serum potentially provides both a 
qualitative and quantitative marker for active infection. Recent overseas studies have 
demonstrated the presence of circulating ES antigens in the serum of T. canis infected dogs 
(Matsumura et al. 1984) and experimentally infected mice and rabbits (Bowman et al. 
1987a; Robertson et al. 1988), using both polyclonal and monoclonal antibodies. Aquila et 
al. (1987) and Robertson et al. (1988) have also reported, in independent studies, the 
presence of these ES antigens in human serum. 
The Christchurch School of Medicine's Department of Surge1y Research Laboratory 
(incorporating the academic Department of Ophthalmology) is the reference centre for T. 
canis serology within New Zealand. In this laboratory, my objective has been the 
development of an assay to detect ES antigens in the serum (and/ or vitreous fluid) of 
seroresponders. This assay should not only be indicative of current infection but also 
provide a means of assessing the level of infection . 
Chapter 2 
Literature Review 
2.1 The Biology of Toxocara canis 
T. canis parasitises a number of canid definitive hosts, but it is dogs who provide the 
major reservoir for human infection throughout the world. For the purposes of this 
review, the life cycle of T. canis will only be outlined for this definitive host. 
2.1.1 Life Cycle in the Dog 
Toxocara canis was first described by Werner in 1782. Since then this parasite has been 
reported in Canidae throughout the world, even at latitudes above 67°N, previously 
considered to be too cold (Christensson, 1988). The lifr cycle of T. canis in the dog is 
complex, involving somatic and tracheal routes of migration which vary according to the 
age and sex of the host (Parsons, 1987). 
5 
While dogs may become directly infected by ingesting embryonated eggs, the most 
common route of infection is congenital transmission (Sprent, 1958). In the pregnant bitch 
it has been shown that both newly hatched larvae and quiescent larvae in the tissue are 
activated, probably by some pregnancy-related signal, resulting in the in utero infection of 
most puppies (Webster, 1958; Sprent, 1958; Scothorn et al. 1965; Burke & Roberson, 1985). 
Lactogenic transmission also occurs, but to a far lesser extent (Burke & Roberson, 1985). 
Prenatal infection results in the accumulation of the larvae in the foetal pup's liver until 
birth. Larvae then commence tracheal migration, passing first to the lungs via the hepatic 
vein, heart and pulmonary artery. During this migration some as yet undefined 
environmental or developmental cue triggers the larvae to grow and moult through the 
subsequent L3 and L4 larval stages and to then mature to the adult form in the intestinal 
lumen, resulting in patent infection (Sprent, 1958). The parasite burden in infected pups 
can range from one to several hundred worms (Glickman & Schantz, 1981). AB each 
gravid female worm is capable of releasing as many as 200,000 eggs per day within four 
weeks of the birth of infected pups, the potential for environmental dispersal is enormous 
(Glickman et al. 1979). The eggs, which are disseminated via the faeces, are undeveloped 
when passed. However, (depending on the conditions where they are voided,) a single 
infective larva usually develops within each egg after several weeks (Parsons, 1987). 
6 
The ability to develop patent infections (Fig.1) is seen only in the definitive host and is 
more common in young pups less than five weeks of age (Sprent, 1958). Reinfection of 
maturing pups has been shown to result in fewer patent infections over time (< 20%) 
(Ghadirian et al. 1976). This has been described as "age related resistance" (Dubey, 1978), 
and is in part related to the infecting dose and to the sex of the animal. The prevalence of 
patent infections in adult dogs is more common in males than in bitches (Glickman & 
Schantz, 1981). Maizels & Meghji (1984) found serum antibody to T. canis surface and 
secreted antigens in male dogs. In spite of this immune response, the animals still 
responded with a patent infection after each dose of infective ova. What is not clear from 
this publication (Maizels & Meghji, 1984) is whether or not this immune response was 
I-independent, which could be expected from an animals tolerized to the antigen at birth. 
In contrast, more larvae are recovered from the tissues of bitches than dogs. These larvae 
undergo somatic migration via the liver and lungs, resulting in systemic distribution. 
Larvae in the tissues have been shown to persist for as long as a year in a 
developmentally arrested state. It is because of this somatic migration pattern in mature 
female dogs that a continuing reservoir of infection can remain in virtually all breeding 
bitches. This reservoir of infection has been demonstrated to persist across three 
Infective eggs 
ingested 
1 
Hatch in stomach 
l 
Migrate through 
tissues 
Egg-producing adult 
worms !n gut of definitive 
hosts (host age/sex and 
dose related) 
=PATENT INFECTION 
Arrested development at 
tissue migratory state i~ 
non-pregnant female 
dogs or p:::i.ratenic hosts 
=SOMATIC INFECTION 
FIGURE 1: Developmental pathway of Toxocara canis following oral ingestion of 
infective ova. 
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consecutive pregnancies, ensuring continued congenital transmission (Ogilvie & de 
Savigny, 1982) 
2.1.2 Infective Larval Stage 
The ingestion of embryonated eggs results in the emergence of the infective L2-stage 
larvae in the gut (Fig.l). The eggs appear to require no specific hatching stimuli which 
possibly explains the wide variety of paratenic hosts in which T. canis is found 
(Abo-Shehada et al. 1984/85). The L2 larvae are approximately 400 um in length and 20 
um in equatorial width, and are surrounded by a thick elastic cuticle which is continuous 
with the linings of the buccal cavity and the oesophagus (Nichol, 1956; Talluri et al. 1986). 
These larvae have the ability to penetrate the gut mucosa, a process thought to be aided 
by the secretion of a parasite-derived, elastase-like protease (Robertson et al. 1989). 
However many fail to penetrate through the gut and are voided (Abo-Shehada et al. 
1984/5). 
2.1.3 Paratenesis 
8 
T. canis larvae have the ability to penetrate the gut mucosa of a broad range of 
mammalian species following the ingestion of infective ova. However, invading larvae in 
these hosts remain developmentally arrested at the L2 stage and only able to undergo 
somatic migration similar to that seen in non-pregnant bitches (Fig.1) (Sprent, 1958). If the 
infected host animal forms part of the food chain of the definitive host, the parasite's life 
cycle is eventually completed, a phenomenon termed paratenesis. A number of paratenic 
hosts have been documented for T. canis. These include rodents, sheep, pigs, chickens and 
earthworms (Glickman & Schantz, 1981). While not a paratenic host in the true sense of 
the word, man is included within this group. The parameters of age and sex have been 
shown to influence the course of infection in mice (Abo-Shehada et al. 1989). It is 
interesting to note that prenatal but not lactogenic transfer has also been demonstrated in 
9 
mice (Abo-Shehada et al. 1984/5). 
2.1.4 Somatic Tissue Distribution 
The tissue distribution of the L2 larvae varies, as does their survival rate, but in all 
instances there appears to be an accumulation of viable larvae in the brain (Dunsmore et 
al. 1983; Nicholas et al. 1984; Abo-Shehada et al. 1991). It was originally thought that 
larvae became trapped within the brain by virtue of their size (Sprent, 1955b). A recent 
study by Prociv (1989) has shown that accumulation at this site is more likely to be due to 
"goal-directed behaviour". 
Larvae that become halted during somatic migration by a host response become 
encapsulated within an eosinophil-dense granulorna (Kayes & Oaks, 1978). They have 
been shown to persist within such granulornas for some years in a state of arrested 
development, also known as diapause. Larvae within these granulomas are unaffected by 
degranulating eosinophils (Rockey et al. 1983; Badley et al. 1987a). The apparent inability 
of the host's immune system to significantly damage the larval cuticle has been attributed 
to the continual secretion of ES antigens by the larvae within the granulomas. The release 
of these antigens from larval surfaces may prevent antibody-mediated cellular adherence 
and subsequent events (Smith et al. 1981). Another possibility is the secretion of 
anti-oxidant enzymes, capable of quenching the highly reactive oxygen species generated 
by activated phagocytes. Studies of other nematodes have revealed the presence of such 
enzymes (Callahan et al. 1988). A recent paper by Maizels & Page (1990) discusses the 
presence of super-oxide dismutase activity within the ES antigens. 
Larvae have the ability to escape cellular encapsulation and continue migrating (Kayes & 
Oaks, 1978). Those which reach the brain remain un-encapsulated and represent a 
reservoir of infection (Sprent, 1958). Behavioural changes follow the accumulation of 
larvae in the brain which may make a parasitized paratenic host more susceptible to 
predation (Sprent, 1955a). 
2.2 Human Infection 
10 
While the close association of humans and dogs increases the likelihood of transmission, 
direct contact with infected dogs plays a secondary role because of the prolonged extrinsic 
incubation period required for voided eggs (Schantz & Glickman, 1978). Infection is more 
likely to result from the ingestion of embryonated eggs, usually associated with 
contaminated vegetation, soil and other fornites. Young children are most at risk of 
infection because of their tendency to put objects in their mouths, combined with their 
interaction with animals and their environment (Gillespie, 1988). 
2.2.1 Environmental Contamination 
Environmental contamination derived from patently infected puppies, usually less than 
three months of age, is thought to be widespread. A warm climate and high humidity are 
important in the development of the infective stage (Glickman et al. 1979). Once 
developed, infective eggs may survive for years, depending on the soil type (Glickman & 
Schantz, 1981) and climate. Nicholas et al. (1986) found sunlight and desiccation promoted 
rapid disintegration of the ova whereas extremely cold weather conditions appear to have 
little effect (Ghadirian et al . 1976). This finding is supported by a study by Borg & 
Woodruff (1973) who found that there was no seasonal variation in the recovery of 
infected eggs from British soil samples. 
2.2.2 Other Risk Factors 
Even though voided eggs need an extrinsic incubation period to reach infectivity, the 
ownership of infected dog(s) must be considered a risk factor. Studies have shown that 
other factors involved in the transmission of T. canis infection to humans are lower 
socioeconomic status, poor personal hygiene and a rural environment (Hermann et al. 
1985). 
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Many young children show a tendency towards pica (putting objects in their mouths) and 
geophagia (eating dirt). These factors combined with those outlined above must 
substantially increase their risk of infection. 
Other special risk groups include people who handle or breed dogs Levels of 5.55% to 
13.9% and 15.5% seropositivity to T. canis have been reported in these groups respectively 
(Woodruff, 1978; Williamson et al. 1988). Similarly the occupationally-exposed hydatid 
control officers throughout New Zealand consistently reveal higher levels of seropositivity 
(27%) than the normal rural population (7%) (Clemett et al. 1985). 
2.2.3 Public Health Significance 
Humans are at risk from embryonated eggs in the soil. Children in densely populated 
urban areas are especially at risk in public parks and playground (Schantz & Glickman, 
1979). Borg & Woodruff (1973) found 24.4% of eight hundred soil samples taken around 
Britain to contain T. canis ova. Ghadirian et al. (1976) found 32.5% of soil samples 
collected from public parks and recreational areas within the city of Montreal to contain T. 
canis ova. A more recent study by Gillespie et al. (1991) found 6.3% of the London parks 
sampled to contain viable ova. Thompson et al. (1986) found 19% of soil samples, taken 
from the peridomestic area of a coastal village in the Caribbean, to be contaminated. This 
same study found 32% of dog faeces sampled to be positive for ova. In contrast, a survey 
of 145 dog faeces, taken in the southern New Zealand city of Dunedin, found only 2.8% to 
be positive for T. canis ova (Dodge, 1980). 
Given the remarkable longevity of the infective ova combined with their resistance to 
freezing weather conditions, the likelihood of the public health risk being increased by a 
gradual build up of soil contamination is a real possibility. 
2.3 Clinical Presentation of Human Infection 
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Most human infections are subclinical, probably because a single infective event does not 
usually generate a major infection (Maizels & Selkirk, 1988). When present, the major 
clinical manifestations are diverse and appear to be related to the number of larvae 
ingested, the organs to which the larvae migrate, host age and the degree of inflammation 
induced by the immune response. The larvae can cause serious systemic and ocular 
disease as they migrate within the tissues of the body, resulting in the presentation of 
either of the two syndromes recognised to be caused by T. canis infection (Fig.2). 
2.3.1 Visceral Larva Migrans (VLM) 
VLM is a clinically recognised, marked inflammatory immune response to undetermined 
numbers of larvae migrating within the liver and other tissues. It is characterised by 
fever, general malaise, hepatomegaly, asthma or respiratory impairment, behavioural 
changes, anorexia, persistent eosinophilia and leucocytosis (Glickman & Schantz, 1981; 
Barriga, 1988). It is usually diagnosed in young children (1 to 5 years of age) with a 
history of pica, geophagia and exposure to puppies. However adults can also present 
with VLM (Glickman et al. 1987). Provided reinfection does not occur, VLM is usually 
considered (perhaps erroneously) self-limiting as these symptoms disappear after 6 to 12 
months. 
2.3.2 Ocular Larva Migrans (OLM) 
OLM is not usually associated with VLM, perhaps because light infestations of larvae are 
ASYMPTOMATIC 
+/- EOSINOPHILIA 
ASYMPTOMATIC 
EGG 
INGESTION 
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MIG RANS 
FIGURE 2: 
VISCERAL LARVA 
MIGRANS 
I RECOVERY 
Pathogenesis of T. canis larva migrans syndromes (Zinkham, 1978; 
Glickman & Schantz, 1981; Barriga, 1988; Taylor et al. 1988; Caucanas et 
al. 1988) 
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able to migrate, unimpeded by the immune response, and do not become apparent until 
one enters an eye (Glickman & Schantz, 1981). Blood eosinophil numbers are normal, or 
only slightly elevated, in these patients (Zinkham, 1978). In some cases a larva present in 
the retina may be slow in inducing inflammation (Olson, 1976) or the inflammation may 
be asymptomatic or nonspecific (Shields, 1984). 
OLM usually occurs in older children (average 8 years) but it may also be diagnosed in 
adults, possibly a consequence of childhood infection. The larvae incite a localised 
eosinophilic inflammatory response which can present in a number of ways, including a 
diffuse, painless endophthalmitis, posterior pole granuloma or peripheral inflammatory 
mass, ie. the pathology varies with the location of the granuloma. A larvae leaving the 
original granuloma and tracking to a new site can induce more inflammation (Sorr et al. 
1984). Inflammation is also usually exacerbated by the death of the larvae (Searl et al. 
1981). Damage within the eye is primarily caused by this inflammatory response with 
retinal damage and resulting loss of vision (Rockey et al. 1979). OLM is recognised to be 
an important cause of childhood blindness. 
Unfortunately the retinal granuloma which can accompany T. canis infection may be 
clinically indistinguishable from retinoblastoma, a highly malignant ocular tumour found 
in children. The importance of being able to differentially diagnose the two conditions has 
been highlighted by the unnecessary enucleation of children's eyes in the past (Wilder, 
1950). 
2.3.3 Covert Toxocariasis 
Antibody testing for T. canis infection has identified a third clinical group which includes 
both adults and children. Labelled "covert" toxocariasis, it's clinical features are either in-
apparent or nonspecific (Glickman et al. 1987; Taylor et al. 1988; Caucanas et al. 1988). 
,.; 
Eosinophilia is not always present. This group may represent a reservoir of infected 
individuals, each with the potential to develop OLM, and may include the enigmatic 
seroresponders reported by Williamson et al. (1988). 
2.4 Current Methods of Detection 
A tentative diagnosis of larva rnigrans, caused by T. canis, may be made on the basis of 
clinical findings. A definitive diagnosis requires either the identification of the larvae in 
biopsied tissues or the detection of ES antigen in the circulation and/or vitreous of 
infected individuals. 
2.4.1 Histological Examination 
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Histological techniques have been developed to visualise T. canis larvae in tissues. Wilder 
(1950) described eosinophilic endophthalmitis, caused by nematode larvae, in the eyes of 
children thought to have retinoblastoma. Nichols (1956) subsequently identified these as 
being T. canis larvae. However examining tissues this way is impractical for diagnosing 
human infection, not only because of the occult nature of most cases of human 
toxocariasis, but also because of the tendency of the larvae to migrate within the body. 
For these reasons histological investigation has been superseded by serological techniques. 
2.4.2 Antibody Assay 
Of the many serological diagnostic tests available for T. canis (reviewed by Voller & de 
Savigny, 1981), the ES antigen-based indirect antibody ELISA is currently accepted as the 
most reliable. Because T. canis remain developmentally arrested at the L2 stage in the 
human host, laboratory diagnosis is based on the detection of antibodies in the serum (or 
vitreous) directed against the ES antigens produced by the L2 larvae in vitro. The use of 
ES antigens in the assay, rather than the adult worm antigens or soluble egg extracts, 
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gives increased specificity (de Savigny & Tizzard, 1977). This may in part be due to the 
absence of the phosphorylcholine epitope found in whole extracts of T. canis larvae, which 
is highly cross-reactive with epitope from many other nematodes (Maizels et al. 1987b). 
Recent studies have focused on the antibody isotype response, especially T. canis-specific 
IgE levels (Brunello et al. 1983; Mclvor et al. 1988). One study of OLM patients showed a 
high IgE response whereas a group of patients with "covert" toxocariasis displayed T. 
canis-directed IgG and IgM antibodies only (Page & Smith, 1988). 
2.4.3 Levels of Circulatory Eosinophils 
Animal studies have found that levels of circulatory eosinophils consistently increase in 
response to T. canis infection (Bisseru, 1969), even when the infecting dose is extremely 
small and insufficient to stimulate a measurable antibody response (Kayes et al. 1985). The 
ES antigens induce a T-dependent, cell mediated immune response which eventually 
results in an eosinophil dense granuloma forming around the larvae. This observation has 
been confirmed histologically with both VLM (Beaver, 1952) and OLM (Wilder, 1950). 
In cases of VLM the eosinophilia is persistent and sustained (de Savigny & Tizzard, 1977; 
Kayes & Oaks, 1980; Glickman & Schantz, 1981). However, in light infestations, 
peripheral eosinophilia may be the only expression of T. canis infection in humans 
(Zinkham, 1978). It is not known how long this eosinophilia lasts. The finding of "covert 
toxocariasis" without any apparent eosinophilia may be due to the loss of the eosinophilic 
response with time (Glickman et al. 1987; Taylor et al. 1988; Caucanas et al. 1988). 
2.4.4 Antigen Detection 
Assays for the detection of circulating antigens (either free or immune-complexed with 
host antibody) provide a means of discriminating active from chronic or past infection, are 
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more indicative of parasite load and (theoretically) are more specific. Changes in the level 
of circulating antigen may also reflect the efficacy of treatment. 
The ES antigens produced by T. canis potentially provide this qualitative and quantitative 
marker for active infection and have been detected in the sera of experimentally infected 
mice for a period of six months following a single infective dose (Bowman et al. 1987a). 
Other studies have demonstrated the presence of circulating ES antigens in T. canis 
infected dogs (Matsumura et al. 1984) and experimentally infected mice and rabbits 
(Bowman et al. 1987a; Robertson et al. 1988), using both polyclonal and monoclonal 
antibodies to capture and visualise the antigen. Aguila et al. (1987) and Robertson et al. 
(1988) have also reported the presence of ES antigens in human sera. 
2.5 Seroepidemiology 
The indirect antibody ELISA is particularly useful in seroepidemiological studies because 
large numbers of serum samples may be efficiently processed (Voller & de Savigny, 1981). 
While this assay in unable to differentiate past from current infection, a positive titre is 
accepted as being indicative of exposure. 
2.5.1 Seroprevalence 
The seroprevalence of toxocariasis is between 2% and 7% of presumably healthy 
populations in developed countries (Barriga, 1988). Initial studies within New Zealand 
were in accord (Clemett et al. 1987), which made the results of subsequent serosurveys of 
selected groups within the country appear very enigmatic (Williamson et al. 1988). The 
most extreme of these is the 83% seropositivity reported amongst rural Maori children. 
Even allowing for ethnic and rural differences, these results rate higher than those 
reported for children aged between 5 and 15 years, living in tropical areas with endemic 
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geohelminthiases (Bundy et al. 1987). This study found between 40% and 60% 
seropositivity in these children from the Caribbean. An earlier study in the same country 
found 86% seropositivity among children under six years of age (Thompson et al. 1986). 
It is difficult to assess the public health significance of this parasite within New Zealand. 
The seroprevalence study by Williamson et al. (1988) indicates that the level of infection is 
higher than appreciated. The one study of dog faeces (in Dunedin) found 2.8% to contain 
T. canis ova (Dodge, 1980). It is now known that embryonated eggs may remain infective 
to definitive and paratenic hosts for many year (Parsons, 1987), therefore the possible 
cumulative effect of environmental contamination cannot be ruled out. 
2.6 Conclusions 
This review highlights the two important reservoirs of T. canis infection within the 
community. One source is the larvae sequestered in the tissues of the pregnant bitch. 
This reservoir ensures the continued vertical transmission of infection within the domestic 
dog population. The second reservoir is the infective eggs in the environment, 
predominantly voided by in utero infected puppies. There is little data concerning 
environmental contamination with T. canis ova within New Zealand. However the high 
levels of seropositivity (27%) shown by the occupationally exposed Hydatid Control 
Officers would suggest environmental levels are at least as high here as in other 
developed countries. 
The predominantly concealed nature of T. canis infection in most humans, coupled with 
the inability of the current assay to differentiate current from past infection, make it 
difficult to assess accurately the enigmatic levels of seropositivity found within New 
Zealand (Williamson et al. 1988). Why does one North Island rural area have a level of 
seropositivity equalling any reported worldwide, while another area (Canterbury) falls 
within the accepted level of 7%. A number of factors can be considered here, including 
increabed dog ownership, lower socioeconomic status, different climate and/ or soil type, 
concurrent exposure to other parasitic infections etc. 
What this highlights is the need for a definitive assay to confirm that seropositivity is 
concurrent with infection in these people. The identification of parasite-derived soluble 
antigens in serum would seem to offer the best prospect of accurate and quantitative 
diagnosis to date. Once established, this assay could then be adapted to diagnose ocular 
toxocariasis by the examination of vitreous fluid. 
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Chapter 3 
ES Antigen Production in vitro 
3.1 Introduction 
The readily cultured form of T. canis (the L2 larva) represents the stage which is 
pathogenic to man. When these larvae are maintained in vitro, they continue to produce a 
group of excretory-secretory (ES) antigens which can be identified in the conditioned 
culture medium for at least 18 months (de Savigny, 1975) . 
The major antigens of ES are glycoproteins with reported Mr of 32,55,70,120 & 400 kD 
(Sugane & Oshima, 1983; Meghji & Maizels, 1986; Badley et al. 1987b). These antigens 
have been found to contain more than 40% carbohydrate, the majority being 
• , 
N-acetylgalactosamine and galactose units (Meghji & Maizels, 1986). The 120 kD antigen 
comprises a set of three closely migrating bands, presenting as a doublet plus a fainter 
band on SDS-PAGE. All three bands bind Tcn-2, a T. canis-specific IgM monoclonal 
antibody, which indicates they are closely related variants of a common molecule (Meghji 
& Maizels, 1986). The 400 kD antigen is not visualised by silver staining. All the major 
antigens have been shown to be immunogenic, to infected patients (Maizels et al. 1984; 
Speiser & Gottstein, 1984; Glickman et al. 1987) and experimental animals (Maizels & 
Meghji, 1984; Glickman et al. 1987) and are employed in the indirect enzyme-linked 
immunosorbent assay (ELISA) used to assess antibody levels (Clemett et al. 1985). 
For this research project in vitro produced ES antigens were combined with an adjuvant to 
vaccinate both a rabbit and a sheep for the production of T. canis-specific antisera. The 
antigens were also used to generate standard curves, as a means of assessing the 
sensitivity of the respective assays being developed to detect circulating antigens. 
3.2 Preparation and Characterisation of Larval ES Antigen 
3.2.1 Isolation and Embryonation of T. canis Eggs 
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Adult worms were obtained from a local animal shelter following the purging of naturally 
infected puppies. Eggs were isolated from the vagina and terminal uterus of individual 
gravid, female worms (Fig.3a). Viable eggs were indicated by the presence of a 
perivitelline space, a regular pitted coat, a dark cytoplasm and sometimes the initial stages 
of cleavage (Fig.3b). In contrast, non-viable eggs usually had an irregular coat and a 
lighter cytoplasm (Fig.3d). Viable, fertilized eggs were pooled from each batch of worms 
and allowed to embryonate to infectivity in 0.05 mol/l sulphuric acid at room 
temperature. After 3-4 weeks eggs contained motile second-stage (L2) infective larvae 
(Fig.3c). Eggs were either stored at 4°C or artificially hatched in vitro (Maizels et al. 1984). 
3.2.2 Hatching of Eggs 
Hatching involved de-coating the eggs until only the flexible inner ascaroide membrane 
remained around the larvae (Fig.3e). It was then completed by bubbling a mixture of 5% 
COi-95% N2 through the egg suspension at 37°C for 30-60 minutes. Careful attention to 
the de-coating stage during the hatching process invariably resulted in the recovery of 
large numbers of viable L2 larvae. On occasion the hatching procedure was repeated from 
this de-coating stage, with no obvious detrimental effect to the larvae. 
3.2.3 Recovery and Maintenance of Larvae 
The infective second stage larvae (Fig.3f) were separated from the hatching debris using a 
specially designed Baermann apparatus (Appendix i). Viable larvae exhibit strong 
sinusoidal movements at 37°C and readily passed through a 20 micron filter into a 
collecting chamber. The L2 larvae were maintained under aseptic conditions in tissue 
culture flasks, suspended in tissue culture media (RPMI) supplemented with 100 IU/ml 
penicillin and 100 ug/rnl streptomycin. It was found that the addition of Gentamicin 
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FIGURE 3: 
(b) 
(d) 
(f) 
Parasite maintenance. (a) Adult female T. canis with the terminal portion 
of the reproductive tract resected to show the vagina (V), terminal uterus 
(U) and ovarian coils (0) (3X); (b) Fertilized T. canis egg with 
perivitelline space (P) (400X); (c) Embryonated T. canis egg (400X); (d) 
Non-viable T. canis egg (400X); (e) Decoated T. canis egg with ascaroid 
membrane (A) (400X); (f) Infective second-stage (L2) T. canis larvae 
(400X). 
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sulphate (40 ug/ml) and Fungizone (5 ug/ml) to each culture also helped prevent 
contamination without any adverse effect on the larvae. The cultures were incubated in 
an atmosphere of 5% C02 at 37°C (de Savigny, 1975). The soluble ES antigens were 
harvested weekly, then dialysed and concentrated prior to use. 
3.2.4 Protein Concentration 
The protein concentration of the dialysed and concentrated ES antigens was assessed by 
UV spectrophotometry at 280nm, with a correction for nucleic acid contamination at 
260nm (Johnstone & Thorpe, 1982). Estimation of the protein concentration by 
measurement of the A280 was confirmed by the Bio-Rad assay, a kitset version of the 
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Bradford protein assay (Bradford, 1976). The Bio-Rad assay is a colourimetric method for 
estimating protein concentration, based on the observation that the absorbance maximum 
for an acidic solution of Coornassie Brilliant Blue G-250 shifts from 465nrn to 595nm when 
binding to protein occurs. It is reputedly more sensitive than absorbance at A280 but has 
the disadvantages of being more time-consuming and the samples taken are not 
recoverable. 
3.2.5 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
The ES antigens produced by the L2 larvae were characterised by gradient polyacrylamide 
gel electrophoresis, using a modification of the method characterised by Laernrnli 
(1970)(Appendix ii). A Pharmacia mini-gel electrophoresis system was used. A gradient 
maker was used to pour 5% - 20% gradient gels of 1.5 mm depth. Aliquoted ES antigens 
were prepared for electrophoresis by the addition of SDS sample buffer (Appendix ii) and 
then heated at 100°C for 3 minutes to aid the dissociation of proteins into their individual 
polypeptide chains. 
. ' 
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3.2.6 Staining Gels for Protein 
The silver staining method described by Morrisey (1981) (without a gluteraldehyde 
fixation step) has been routinely used in our laboratory for the staining of T. canis ES 
antigens. This stain differs from other silver stains in that the gel is treated with 
dithiothreitol prior to staining (Appendix iii). The use of Farmer's reducer to enhance the 
staining process was also evaluated (Appendix iv). Farmer's reducer is said to remove 
the weak grey film on the gel surface and the slight shading, while at the same time 
increasing the contrast. (Heukeshiven & Demick, 1985). 
3.3 Results 
Estimation of the protein concentration showed both methods tested were comparable, 
with the Bio-Rad assay showing a slightly lower concentration of protein present (results 
not shown). 
SDS-polyacrylarnide gel electrophoresis (-PAGE), with a linear gradient of 5% - 20% 
polyacrylarnide, gave good resolution of the proteins present in the ES antigen 
preparation. The ES antigens are known to be comprised of a wide range of 
glycoproteins. However, those of more than 10% carbohydrate are known to behave 
anomalously during SOS-PAGE compared to standard proteins; a result of decreased 
binding of SDS. This results in a decreased charge to mass ratio, decreased mobility 
during SDS-gel electrophoresis and therefore a higher apparent molecular weight. It has 
been found that this effect can be minimised by the use of a gradient gel. With an 
increased gradient concentration, the molecular sieving effect increases, taking precedence 
over the decreased charge to mass ratio (Lambin, 1978). 
The optimum protein concentration to load on a gel, (found by loading doubling dilutions 
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of the antigens), was 2 ug. It was found that the use of a sample buffer containing no 
mercaptoethanol (i.e. non-reducing conditions) gave the best resolution of the components. 
A comparison between Morrisey' s silver stain and a colloidal Coomassie method proved 
the former to be the most sensitive for visualising the discrete antigens (results not 
shown). This is in accord with published evidence indicating its increased sensitivity over 
Coornassie blue staining (Meghji & Maizels, 1986). The use of Farmer's reducer after 
staining not only reduced background staining but also increased contrast and sensitivity. 
Rainbow Markers<TM) from Arnersham were included in every gel run to enable a 
molecular weight standard curve to be calculated. This product includes a range of 
individually coloured protein molecular weight markers, ranging from 14.3 - 200 kD. 
After staining the gel, the relative mobility (Rf) of each calibration protein was calculated. 
These relative mobilities were then plotted on semi-log paper against the known molecular 
weights of the standards. The relative molecular weight (Mr) of each ES component was 
then calculated by interpolation. Lambin (1978) reported that when SDS and a gradient 
gel are combined, a linear relationship can still be expected, even when the proteins are 
glycosylated and the molecular weights are wide ranging. 
All samples of ES antigens produced during the course of this study were assessed by 
gradient SDS-PAGE and silver staining. Remarkably little sample to sample variation was 
seen. When variation did occur, it was generally in the more minor antigen bands. Any 
batches showing atypical bands were discarded. 
Fig.4 shows ES antigens collected from two batches of larvae, by two different 
FIGURE 4: 
(a) (b) (c) (d) 
Mr (kD) 
125 
80 
45 
34 
29 
T. canis derived ES antigens resolved by gradient SDS-PAGE and 
silver staining. (Lanes) (a) 1 µg ES antigen (1991) (b) 2.5 µl Rainbow 
Markers TM (Arnersham) (c) 1.25 µg ES antigen (1989) (d) 2.5 µg ES 
antigen (1989). Samples were run under non-reducing conditions (i.e. 
mercaptoethanol was omitted from the SOS sample buffer) in a gradient 
gel (5-20%). Mr for the sample bands is indicated. 
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investigators and two years apart. Calculation of the molecular weights revealed 
prominent antigens of approx. 125, 80, 45, 34 and 29 kD in both batches. While these 
molecular weights may differ slightly from those documented by other investigators, it is 
important to note that both batches are very similar. This is in contrast to Speiser & 
Gottstein (1984) who found considerable batch to batch variation in their antigen 
preparations. 
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Chapter 4 
Detection of ES Antigens using Polydonal Antisera 
4.1 Introduction 
Two well documented syndromes are caused by T. canis infection. These are visceral larva 
migrans (VLM) and ocular larva migrans (OLM). A positive antibody titre in these 
patients supports clinical findings. However, seroprevalence is often much higher than 
would be anticipated from the occurrence of the disease. This has led to the presumptive 
identification of a third clinical group, labelled "covert tox::>cariasis" because of the 
inapparent or nonspecific clinical features (Glick.man et al. 1987; Taylor et al. 1988; 
Caucanas et al. 1988). 
The indirect antibody ELISA makes no discrimination between currently infected 
individuals and those with an immune response due to past, or even abortive exposure to 
the parasite. The duration of immunological memory to T. canis infection is unknown, but 
antibody levels are thought to fall over time if not re-challenged. It is possible that an 
apparently high seroresponse is maintained in some individuals by a cross-reacting 
antigenic epitope. In those who are currently infected, a seroresponse provides no 
indication of the magnitude or site of infection. 
An additional drawback in basing a diagnosis on positive antibody serology alone is that 
not all ES antigens produced are T. canis specific (Maizels et al. 1984). Reaction to ES 
antigens has been shown to be reduced in sera adsorbed against non-homologous 
parasites (including Giardia sp.) (Lynch et al. 1988a; 1988b). Smith et al. (1983) also 
reported increased titres in the antibody assay due to the presence of heterophile 
antibodies to the blood group antigens, known to be presented by T. canis. C-reactive 
.. 
protein has also been shown to cross-react with a toxocara embryonated egg extract 
(Cypess et al. 1977). 
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False negatives in T. canis serology can also present a problem when a diagnosis is based 
solely on the detection of circulatory antibodies. Clinically diagnosed cases of OLM can 
be seronegative by the current serum antibody ELISA (Clemett et al. 1986). This 
observation is supported by experimental studies which showed that infection with less 
than 25 infective ova failed to elicit a detectable antibody response in mice, despite 
detectable alterations in the number of circulating eosinophils (Kayes et al. 1985). 
It is this potential for both false positives and negatives in the current diagnostic assay for 
T. canis which emphasises the need for a definitive assay to establish the presence of T. 
canis. T. canis larvae are known to produce ES antigens in vivo as well as in vitro (Parsons 
et al. 1986). The detection of these antigens in serum would not only be indicative of 
current infection, but may also provide a means for assessing the level of infection. The 
ability to detect T. canis antigens in vitreous samples in the early stages of infection would 
also provide a definitive diagnosis for the ophthalmologist. 
4.2 Detection of in vivo produced ES Antigens using Polyclonal Antisera 
Matsumura et al. (1984) and Bowman et al. (1987a) both described the presence of 
circulating toxocaral antigens in the sera of T. canis-infected dogs and experimentally 
infected mice respectively. A sandwich ELISA was used in both studies. An IgG rabbit 
antiserum to the ES antigens was used as a capture antibody and an enzyme-conjugated 
form of the same rabbit IgG as a second antibody. Matsumura et al. (1984) pre-adsorbed 
their antisera against Ascaris lumbricoides and Fasciola hepatica to eliminate cross-reactivity. 
Bowman et al. (1987a) detected circulating antigen in their mice one week following 
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infection. While the level of free antigen fell sharply as an 1·rnrn d · une response occurre m 
these animals, EDTA/heat treatment of the sera to dissociate immune complexes (4.2.2) 
revealed a consistently high antigen recovery for the 6 month period of investigation. 
Matsumura et al. (1984) only tested for free antigen in dogs which ranged in age from 
foetuses to three years and older. The highest levels were found in puppies aged one 
month. 
In light of the success of these studies using polyclonal antisera to detect circulating ES 
antigens, two ELISAs were set up to detect similar antigens in human sera. 
4.2.1 Production & Characterisation of Polyclonal Antisera 
Hyperirnrnune antisera were prepared by vaccinating a sheep (subcutaneously in the back 
of the neck) and a rabbit (subcutaneously in the back) with 100 ug of ES antigen each. 
The antigen preparation was suspended in the L121 adjuvant, a non-ionic Pluronic 
polymer formulation (Allison & Byars, 1986). This type of adjuvant was developed for its 
ability to provide a large surface area for antigen retention, from which the antigens can 
be readily transferred to antigen-presenting cells. After four weeks both animals were 
re-vaccinated with a similar preparation. The secondary antibody response was allowed 
to develop over another two-three weeks before immune sera was collected from each 
animal. The sheep was bled through the jugular vein while blood was collected from the 
artery running through the ear in the rabbit. Each blood sample was allowed to clot and 
then centrifuged to separate the serum. Sera were then aliquoted and stored at -20°C. 
Initially a quantitative assessment of the antibody response of each animal was 
determined by indirect antibody ELISA (Clernett et al. 1985). The sera were assayed at a 
1:1000 dilution which has been found to discriminate well between positive and negative 
control sera. Results were then expressed in absorbance values. The positive/negative 
discrimination level (O.D.492 = 0.70) was set at the 97.Sth percentile of 300 adult blood 
donors (Clemett et al. 1986). 
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To ensure that the polyclonal antibody response to the in vitro derived products of the L2 
larvae measured by ELISA showed a similar qualitative response to that found during 
natural infection, each sera was assessed by binding to ES antigens (Appendix v). The ES 
antigens were first separated on a gradient SDS-acrylamide gel and then transferred 
electrophoretically to nitrocellulose (NC) membrane. This method was adapted from the 
original method of Towbin et al. (1979). In order to achieve the best transfer of ES 
antigens from the gel to the NC membrane (with limited loss in resolution), transfer 
conditions for this process were optimized by the inclusion of SDS (0.02%) and methanol 
(10%) in the transfer buffer (Towbin & Gordon, 1984). Although methanol has been 
reported to decrease elution efficiency, in this particular instance it appeared to increase 
the binding capacity of the NC by strengthening hydrophobic interactions i.e. it displayed 
a fixative effect. The addition of detergent (eg 0.02% SDS) to the transfer buffer facilitated 
the elution of the high molecular weight antigens. Optimizing the transfer conditions also 
included testing for leakage of antigens through the NC membrane. 
Following transfer, strips of the antigen-coated NC membrane were individually probed 
with the immune sera from each animal. The sera were diluted in 5% fetal calf serum 
(FCS) in PBS/0.05% tween, the FCS being added as a blocking agent to eliminate 
non-specific antibody binding. Positive (from an OLM patient) and negative human sera 
(determined by indirect ELISA) were used as controls. Horse radish peroxidase 
(HRP)-labelled anti-species antibodies, coupled to an enzyme-detecting chromogen were 
used to detect the individual primary antibodies bound to the immobilized antigens 
(Fig.5) (Appendix v). 
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FIGURE 5: 
(a) (b) (c) (d) 
Immunoblotting serum profiles of polyclonal antibodies to T. canis ES 
antigens. (Lanes) (a) Antibody-positive sheep (0.D.492 = 1.5) (b) 
Antibody-positive rabbit (0.D.492 = 1.5) (c) A 9 year old human with 
presumed ocular toxocariasis (0.D.492 = 1.6) (d) Normal human serum 
(O.D.
492 
= 0.2). ES antigens were separated on a gradient SOS-PAGE gel, 
blotted to nitrocellulose and probed with the antibody. Mr is indicated 
on the left. 
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In general, polyclonal antisera contain only about 1 % imrnunoglobulin directed against the 
desired epitope. To increase the sensitivity of the rabbit anti-ES antiserum in the assays to 
follow, the IgG fraction was first isolated by DEAE (diethylaminoethyl) Affi-GEL blue 
column (Bio-Rad) (Appendix vi). Following dialysis against PBS, this IgG fraction was 
then affinity purified by passing it down a column containing ES antigens bound to 
nitrocellulose (Appendix vii). 
4.2.2 Dissociation of Immune Complexes 
Sera containing negligible antibodies towards T. canis (normal human sera or NHS) and 
immune human sera (IHS) from Hydatid Control Officers were seeded with increasing 
concentrations of ES antigens. Incubating the samples for 2 hours at 37°C allowed 
immune complexes to form (highlighted in Fig.9 by the Hydatid Officers sera where 
indicator antibody binding was completely abrogated.) These sera were then tested for the 
presence of antigen, before and after a treatment to dissociate immune complexes present. 
Two treatments were tried. The first involved mixing the sample with an equal volume of 
0.2 M EDTA (pH 8.0), then heating for 5 minutes at 100°C (Bowman et al. 1987a). The 
sample was then centrifuged at 7,000g for one minute, re-suspended and centrifuged at 
the same speed for another minute. The resulting supernatant was assayed for the 
presence of ES antigens. 
A second method using polyethylene glycol and heat was trialled (Bowman, 1987a). It 
was found to be comparable to EDTA/heat in terms of antigen recovery but more 
time-consuming. It was not pursued. 
4.2.3 Sandwich ELISA 
Sandwich or antigen capture ELISAs use antibody bound to a stationary phase 
(immunoassay plate) to specifically bind the antigen to be measured. 
In this assay, the previously prepared sheep anti-T. canis antisera was used as the bound 
stationary phase. The rabbit antisera was then used as the top antibody, to bind and 
detect the antigens. An enzyme-linked anti-rabbit antibody was used to detect bound 
rabbit IgG (Appendix vix). 
4.2.4 Competitive Inhibition ELISA 
The principle of a competitive inhibition ELISA method is that any antigen in a test 
sample will form immune complexes when pre-incubated with the known indicator 
antisera, thereby proportionally reducing the amount of antibody free to bind to a 
standardized antigen coated plate. 
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In this assay, test sera were incubated with the previously prepared affinity-purified rabbit 
indicator antibody for 2 hours at 37°C before being transferred to an ES antigen coated 
plate. Excess serum was washed off before the level of indicator antibody binding was 
assessed using an enzyme-conjugated anti-rabbit antibody (Appendix x). 
A standard curve for this assay was generated by the addition of doubling amounts of ES 
antigens (produced in vitro) to normal human sera and immune human sera, pooled from 
clinically diagnosed VLM/OLM cases. After incubation to allow immune complexes to 
form, each sample was divided to form two sets of identical standards. One set of 
standards was then treated with EDTA/heat before both sets were assayed and compared 
for the presence of ES antigens (4.2.2) . 
4.3 Results 
4.3.1 Polyclonal Antiserum Production 
Hyperirnrnunisation of both animals resulted in two polyclonal antisera against the ES 
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antigens. This was confirmed by indirect ELISA, using a serum dilution of 1:1000 
(Clemett et al. 1985). The rabbit and sheep antisera both gave similar absorbances (O.D.
492 
of 1.492 & 1.450 respectively). 
Imrnunoblotting was performed to compare the patterns of polyclonal antisera reactivity 
to SDS-PAGE separated ES antigens (Fig.S). It has been calculated that as little as 1-2 ng 
of specific protein can be detected with the appropriate hyperimmune antisera (Burnette, 
1981). The lanes in the blot shown here each contained approximately 1.7 ng of ES 
antigens. All the ES antigens detected by SDS-PAGE and silver staining (Fig.4) were also 
detected by three anti-ES sera compared in the blot (Fig.S). Additional bands, not visible 
on the silver stained gel, were also seen on the corresponding blot. 
Sensitivity in immunoblotting is primarily a function of the titre of the specific antibody in 
each immune serum being utilized. Regardless of the antibody source (ie.sheep, rabbit, 
human), all three ELISA positive antisera showed a common pattern of reactivity with 
respect to the number of antigenic components (Fig.S). Major bands were detected at 
130-140, 85, 42 & 30 kD. The sheep and rabbit polyclonal antisera detected bands at 80, 
47, 37, 34 & 26 kD, plus two very faint bands at 57 & 52 kD. The serum from the OLM 
patient also recognised bands at 37, 34 & 26 kD, as well as very faint bands at 80, 57 & 47 
kD. No band was visualised at 52 kD with this antiserum. 
A faint band, calculated to be 230 kD was also visible on the blot developed with the 
rabbit and human antisera. This band corresponded to the boundary of the stacking gel 
and may be the 400 kD macromolecule reported by other authors (Maizels et al. 1984; 
Meghji & Maizels, 1986; Kennedy et al. 1987). 
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4.3.2 Affinity Purified IgG Antibody Production 
Purification of the lgG fraction from the rabbit anti-T. canis antiserum, followed by affinity 
purification, resulted in a highly specific reagent, with an absorbance of 1.340 (0.D.
492
) at 
100-fold dilution. Because of the reported cross-reactivity between antigenic epitopes on 
human red blood cell A & B antigens, the L2 larval surface and the ES antigens, the 
affinity purified antibody was adsorbed against human AB +ve red blood (Smith et al. 
1983).(Appendix viii). This resulted in a slightly reduced titre of antibody binding 
(0.D.492 = 1.311). 
4.3.3 Sandwich ELISA 
Preliminary checkerboard titration to establish optimum working dilutions for the 
sandwich ELISA showed an unacceptable level of nonspecific binding between the sheep 
anti-ES coating the immunoassay plate (2 ug/rnl) and the rabbit anti-ES used as the 
detection antibody. This nonspecific binding occurred, regardless of attempts to block the 
antibody-sensitized plate with 53 fetal calf serum, presumably as a result of the presence 
of heterophile antibodies (results not shown). 
4.3.4 Competitive Inhibition ELISA 
The standard curve generated using the competitive inhibition ELISA and the 
affinity-purified rabbit IgG antiserum (Fig.6) showed a similar level of sensitivity to that 
published by Robertson et al. (1988) using a T. canis specific monoclonal antibody. Both 
assays detected the presence of added ES antigens in NHS at 20 ng/ml. Because the assay 
being tested here was based on competitive inhibition, the standard containing no ES 
antigens allowed the greatest indicator antibody binding and vice versa. Competition 
between the antibodies present in the IHS and the indicator antibody was demonstrated 
by decreased levels of indicator antibody binding, especially at the lower ES 
concentrations (Fig.7). 
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immune complexes. 
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The same recovery of the ES standards was obtained from both NHS and IHS after 
EDTA/heat treatment (4.2.2) to dissociate any immune complexes (Fig.7). However an 
anomaly was noted in this assay. The decreased binding of affinity-purified rabbit 
indicator antibody by the ES antigens in the EDTA/heated treated NHS standards over 
those in NHS alone. This resulted in the plate-bound ES antigens binding more indicator 
antibody 1n the EDTA/heat treated samples. This is seen in Fig.7 where the NHS-PBS line 
lies below that of the same batch of standards treated with EDT A/heat 
(NHS-EDT A/heat). 
Because this difference was apparent in the control standard (i.e. NHS without ES 
antigens), it would suggest the presence of a heat labile substance in NHS, capable of 
binding either the affinity purified rabbit polyclonal antibody or directly competing with it 
for epitopes on the ES antigens. However, the difference between NHS and EDTA/heat 
treated NHS was not consistent but increased with increasing ES antigen concentrations 
(Fig.7). This would suggest that ES antigen reactivity was somehow being diminished 
under these conditions. Two possibilities include antigen being dragged down with the 
precipitate on centrifugation after heating and/or the degradation of epitopes on the ES 
antigens recognised by the polyclonal indicator antibody. Because the antigen 
concentration was the only variable in this assay, it would follow that greater 
concentrations of antigen meant proportionally greater epitope degradation and hence less 
availability to bind antibody. 
With apparently consistent recovery of ES antigens from the artificial complexes following 
EDTA/heat treatment, the assay was used to examine a number of test sera for the 
presence of ES antigens. These antibody positive sera (from dog breeders) were treated 
with EDTA/heat to dissociate any immune complexes present prior to being assayed. No 
ES antigens were detected in any of the test sera (see Results Summary for comment). 
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Chapter 5 
Detection of ES Antigens using a T. canis-specific Monoclonal Antibody 
5.1 Introduction 
Several groups have independently developed panels of monoclonal antibodies directed 
against T. canis (Bowman et al. 1987b; Aguila et al. 1987; Maizels et al. 1987a). Both 
Bowman and Maizels reported the isolation of IgM monoclonals with apparent 
species-specificity for T. canis. While there was inconsistency in which antigens were 
being recognised (as determined by molecular weight), both groups reported their 
respective antibodies recognised epitopes common to the surface of the infective-stage 
larva and in the excretory-secretory (ES) antigens. Aguila et al. (1988) also developed and 
characterised a panel of five monoclonal antibodies against the ES antigens. Of these, Tc-1 
(IgGl) was chosen for diagnostic work because of it specificity and lack of reactivity with 
C-reactive protein or human/bovine serum albumin. 
Aguila et al. (1987) and Robertson et al. (1988) have used these T. canis-directed 
monoclonal antibodies to detect un-complexed ES antigens in human serum. Robertson's 
study and another by Gillespie et al. (unpublished to date) used Tcn-2, one of the T. 
canis-derived monoclonal antibodies developed by Maizels et al. (1987a). This particular 
monoclonal antibody was subsequently chosen for diagnostic work because of it's species 
specificity (Kennedy et al. 1987) and apparent sensitivity, detecting ES antigens in nonnal 
human serum at a concentration of 20 ng/ml or greater (Robertson et al. 1988). 
I was given the opportunity to take one thousand serum samples from New Zealand to 
the laboratories in London where the above studies were undertaken. These sera included 
the three groups of enigmatic seroresponders found by Williamson et al . (1988). The 
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remainder of this chapter outlines the methods I used there in the attempt to demonstrate 
free and complexed ES antigens in these serum samples. 
5.2 Detection of in vivo produced ES Antigens using T. canis-specific Monoclonal 
Antibody 
5.2.l Production and Characterisation of the Monoclonal Antibody Tcn-2 
Tcn-2 is an IgM isotype monoclonal antibody, raised in BALB/C mice against whole ES 
antigens and purified from ascitic fluid by Superose 6 FPLC Gel filtration (Maizels et al. 
1987a). This antibody recognises a repetitive, heat-stable glycosylated epitope present on 
nearly all the major ES antigens (55, 70, 120, 400 kD), the exception being the 32 kD 
antigen. These antigens are found on both the surface and in the excretory-secretory (ES) 
antigens of T. canis (Maizels et al. 1987a; Kennedy et al. 1987). 
5.2.2 Dissociation of Immune Complexes 
Two methods were used to dissociate immune complexes. These included EDTA/heat 
treatment (see 4.2.2), which was also the method used by Robertson's group in their study. 
A second method involved dissociating the complexes in 0.1 M glycine-HCI at pH 2.0 at 
room temperature for varying lengths of time before neutralizing the sample with a 
glycine buffer (Maizels et al. 1987b). This second method was trialled because it was 
suggested that there was no need to use heat if the sample was acidified for long enough. 
5.2.3 Two site/Single step Assay for Antigen Detection 
This method is a two-site antigen capture ELISA which has been shown to be sensitive for 
the detection of parasite products in other nematode parasitisms (Maizels et al. 1985). 
Robertson et al. (1988) used this antigen capture method to detect free circulating ES 
antigens in human serum samples. This ELISA configuration involved a capture antibody 
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(Tcn-2) as the bound stationary phase and HRP-Tcn-2 as the enzyme-labelled top antibody 
to detect captured antigen. 
The test sera (at a final concentration of 1/10) were premixed with HRP-labelled Tcn-2. 
After 2 hours incubation at 37°C, the samples were added to the Tcn-2 coated wells in an 
ELISA plate, hence the term "single step" (Appendix xi). A standard curve was generated 
for this assay by the addition of doubling amounts of ES antigens (produced in vitro) to 
normal human sera (NHS). 
5.2.4 Two site/Two step Assay 
The Toxocara Reference Laboratory used a modification of the single step assay outlined 
above. The method was essentially the same, except the layers were applied individually, 
rather than premixing the serum sample and enzyme-labelled monoclonal antibody. To 
differentiate the two assays, this assay is termed "two step" (Appendix xii). 
5.3 Results 
The standard curve for the two-site/single step assay for antigen detection attained a 
similar level of sensitivity as that reported by Robertson et al. (1988) (Fig.8). 
Using this assay, sera from four groups of seroresponders were tested for the presence of 
freely circulating antigen. These included "at-risk" hydatid control officers and the three 
groups of enigmatic seroresponders described by Williamson et al. (1988). All sera were 
tested in duplicate and day-to-day variation was controlled by the addition of an ES 
antigen standard (positive) and normal human serum (negative). A number of sera in 
each group tested antigen positive (Table 1). 
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Fig 9: Standard curve to detect ES antigens pre-incubated with human 
sere testing positive in a T. canis antibody ELISA. 
. : 
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Table 1: Detection of ES antigens with Tcn-2, using a two-site/single step assay§. 
Number of Positive Sera 
(O.D.40.J• (Diagnostic 
Group n index)8 
Post-partum Mothers 55 8 (15%) 1 (2%) 
M.E. Patients 78 13 (17%) 9 (12%) 
Maori Children 538 172 (32%) 62 (12%) 
Hydatid Control Officers 43 2 (5%) 0 
§ These samples were neither treated with EDTA or heat prior to analysis 
+ Positives (> 20 ng/rnl) determined by standard curve 
9 Positives determined by O.D.405 being> 3 ti:nes that of NHS (Aguila et al. 1987.) 
A diagnostic index was also determined (0.D.492 of the test sera/0.D.492 of the negative 
controls), with values > 3 being considered positive (Table 1) (Aguila et al. 1987). This 
significantly reduced the number of sera considered positive (Appendix xiii). 
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Treatment of some of the positive sera with EDTA/heat (Chapter 4.2.2) to dissociate any 
immune complexes present resulted consistently in the loss of signal (Table 2). An 
alternative method of dissociating immune complexes without the use of heat was 
investigated. The results were inconsistent. A comparison of both these methods has 
since shown that the sample has to be heated (> 80°C) to guarantee the abrogation of any 
T. canis-specific antibody binding. 
A number of the sera were retested using a slight modification of the two-site/two step 
assay used at the U.K.Toxocara Reference Laboratory. A number of samples that were 
positive using the two-site/single step assay were negative using this two-step sandwich 
technique (Table 3)(Appendix xiv). A standard curve generated for this two site/two step 
assay also showed a loss of sensitivity of approximately one order of magnitude (Fig.8). 
To test the status of samples that were antibody positive but negative in the 
two-site/ single step assay, artificial complexes were formed by the addition of ES antigens 
to immune human sera. ES antigen concentrations were the same as those used to 
generate the standard curve in NHS. Individual sera, shown by the two-site/single step 
assay to have no freely circulating ES antigens present (within the level of sensitivity 
established for this assay), were grouped to form two pools of sera from Maori children 
testing positive in a T. canis antibody ELISA and a separate pool from antibody positive 
Hydatid Control Officers. 
The two-site/single step assay was used to assay these ES-antigen seeded sera for 
TABLE 2: Evaluation of antigen positive sera before and after treatment to dissociate 
immune complexes. 
• 
e 
Untreated Sera• 
(O.D.4os> 
0.112 
0.101 
0.156 
0.106 
0.123 
0.120 
0.178 
0.123 
0.119 (Serum 151) 
0.057 (NHS) 
Uncomplexed ES antigen 
Total ES antigen 
EDT A/Heat treated Sera8 
(O.D.405) 
0.061 
0.059 
0.057 
0.065 
0.069 
0.059 
0.059 
0.059 
0.059 
-
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TABLE 3: Comparison of two assays to detect ES antigens in sera. 
Number of Positive Sera• 
Two-site/single Two-siteffwo step 
Group n step 
Post-partum Mothers 13 4 (31 %) 1 (8%) 
M.E. Patients 14 11 (79%) 0 
Maori Children 50 22 (44%) 2 (4%)0 
• As determined by standard curve, absorbance > 0.1 at 0.D.405 
8 0.D.405: 0.422 & 0.573 (i.e. strong positives) 
unbound antigen. No free antigen was detected at any antigen concentration in the 
Hydatid Officers sera whereas the Maori childrens' sera returned a curve virtually 
identical to the standard curve generated in NHS (Fig.9) (See Results Summary). 
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Chapter 6 
Results Summary 
The initial part of this research project focused on the detection of ES antigens in human 
sera with the use of polyclonal antisera produced against T. canis. Two irnmunoassays 
were compared for their sensitivity and specificity. A Sandwich ELISA, which employed 
two different polyclonal antisera as the immobilised and top coats respectively, showed 
cross-reactivity between the immobilised sheep antibody and the coating rabbit antibody 
despite steps to block non-specific binding. For this reason it was not pursued. 
In contrast, preliminary results from the Competitive Inhibition ELISA showed a similar 
level of sensitivity to that previously published (Fig.6). However this assay also revealed 
a number of disturbing results when in vitro produced ES antigens were used to generate 
standard curves. The level of indicator antibody binding to the plate-bound ES antigens 
was increased following EDT A/heat treatment of the control standard (containing no ES 
antigen). This increased binding of the indicator antibody suggests that NHS contains 
some kind of heat-labile epitope(s) that either binds the affinity purified rabbit IgG 
polyclonal antibody or competes with it for binding sites on the plate-bound ES antigens. 
Secondly, with no ES antigens added, little difference was noted between EDT A/heat 
treated NHS and EDTA/heat treated IHS from clinically positive VLM/OLM patients. 
Whilst it could be expected that EDTA/heat treatment had destroyed anti-ES antibodies in 
the IHS, it should not have destroyed any pre-existing ES antigens. If present in sufficient 
concentration, these antigens should have been able to compete for the affinity purified 
rabbit IgG polyclonal indicator antibody and hence significantly reduce the antibody 
available to bind the plate-bound ES antigens. This was not observed, possibly because 
the levels of circulating ES antigens in the IHS were too low to make a difference to the 
; 
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Competitive Inhibition ELISA. No circulating ES antigens were detected in sera from dog 
breeders and Hydatid Control Officers tested by this assay, following EDTA/heat 
trEatment. It is also conceivable that these test sera, although antibody positive for ES 
antigen, had no current infection and hence undetectable levels of ES antigens in 
circulation. 
It was also noted in the standards that as the concentration of ES antigens increased, the 
ability to detect the same levels of these antigens decreased following EDTA/heat 
treatment. This suggests that either ES antigen is itself heat denatured (or has heat labile 
epitopes) or it is co-precipitating during centrifugation. Inability to easily resolve this 
issue, combined with overseas publications citing the detection of ES antigens in human 
sera, prompted the investigation of the monoclonal-based antigen detection assays. 
The availability of these monoclonal antibodies suggested an improved approach to 
Toxocara diagnosis. Robertson et al. (1988) reported the presence of significant levels of 
un-complexed ES antigens (P < 0.01) in a number of human sera, using a two-site/single 
step assay in conjunction with the monoclonal antibody, Tcn-2. His group chose this 
particular monoclonal antibody for diagnostic studies from a panel of eight because of its 
lack of cross-reactivity with either closely related Ascaroid parasites or phosphorylcholine, 
a common irnrnunogenic determinant in nematodes (Maizels et al.. 1987b). 
My subsequent studies in the United Kingdom, using Tcn-2 and a two-site/single step 
assay, established a standard curve with a similar level of sensitivity to that published by 
Robertson et al. (1988). Preliminary examination of the New Zealand sera revealed a 
number that were antigen positive within the three groups of enigmatic seroresponders 
being investigated, i.e. post-partum mothers, M.E. patients and the rural Maori children. 
In contrast, antigen was detected in a far smaller proportion of the "at risk" Hydatid 
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Officers' sera (Table 1). 
A criteria other than the standard curve was also applied to the results to establish 
positivity. This involved determining the diagnostic index for each sample (Aguila, 1987). 
As can be seen from Table 1, this dramatically altered the interpretation of the results. 
The number of antigen positive sera fell from 5% to zero within the hydatid officers and 
from 14% to 2% within the post-partum mothers. The antigen positive Maori children's 
sera fell from 32% (by standard curve) to 12% (by diagnostic index). However the number 
of positive M.E. patients only fell from 17% to 12%. 
A small number of sera testing positive for un-complexed ES antigens in the 
two-site / single step assay were treated to dissociate immune complexes, using the 
EDT A/heat method. This should have resulted in a similar, if not higher, recovery of 
total ES antigens. However this treatment resulted in loss of the signal in all these sera 
(Table 2). Because it was thought that heating the sample may cause antigen loss, an 
alternative way of dissociating immune complexes was investigated which involved the 
use of acid and glycine. It was not found to be reliable. Subsequent studies have shown 
that heat (> 80°C) has to be used to destroy antibody reactivity to T. canis (Results not 
shown). 
A brief discussion with Robertson at this time revealed a similar anomaly when he heat 
treated his "antigen positive" sera and tested for total ES antigens using the 
two-site/single step assay. This was not mentioned in his publication (1988). The 
subsequent EDTA/heat treatment of one of these sera (No.151) resulted in a decrease in 
optical density from 0.119 to 0.053. This represents a decrease in ES antigens from 37 
ng/ml to less than 20 ng/ml, below the resolution of this assay. 
A number of samples that tested positive using the two-site assay /single step assay 
returned a negative result using the two-step, sandwich style antigen assay used by the 
Toxocara Reference Laboratory (Table 3). Similarly, a standard curve generated in NHS 
showed considerably less sensitivity by this assay (Fig.8). The use of radiolabelled ES 
antigens, premixed with NHS, to investigate this anomaly also supported this finding. 
However, this result was unable to be investigated further because of insufficient Tcn-2 
monoclonal antibody. This finding is, however, in agreement with Dissanayake et al .. 
(1984). who also reported increased sensitivity using the two-site/single-step assay over 
the two-site/two step assay when detecting circulating antigen in Bancroftian filariasis. 
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Following the incubation of ES antigens with sera from Hydatid Control Officers for 2 
hours at 37°C, the two-site/single step assay was unable to detect any un-complexed ES 
antigens (Fig.9). In contrast, a few sera from Mlori children, strongly positive in a T. canis 
antibody ELISA and chosen at random to form a pool of immune human sera, displayed 
an apparent inability to complex with the Tcn-2 specific ES epitope. This resulted in a 
curve (Fig.9) similar to that obtained when ES antigens were added to NHS and measured 
by the same assay (Fig.8). This inability to bind Tcn-2 in the two-site/single step assay 
strongly suggests that these sera from the Maori children do not contain specific ES 
antigen directed antibodies. The apparent seroresponse to T. canis may have resulted from 
low affinity antibodies produced in response to a similarly glycosylated epitope. 
Given the enigmatically high seropositivity of the Maori children (Williamson et al.. 1988) 
it would seem that the putative diagnosis of seropositivity (Clemett et al .. 1986) is not 
representative of T. canis infection in this group. 
The 12% (by diagnostic index) of Maori children who were positive by the two-site/single 
step assay is probably more representative of T. canis infection. 
Chapter 7 
7.1 Discussion 
7.1.1 Introduction 
Toxocariasis is known to be a widespread zoonosis. Increasing numbers of clinical cases 
of infection, both visceral and ocular, are being reported within New Zealand. This is in 
contrast to 22 years ago, when only one case of VLM had been diagnosed at a major 
children's hospital in New Zealand over a seven year period (Charleston, 1977). The 
results of serosurveys within the country, using the current diagnostic ELISA and 
measuring a polyclonal antibody response, suggest that T. canis infection is more 
widespread than previously imagined, especially in those occupationally exposed and in 
the rural community (Williamson et al. 1988). However it is not possible to establish the 
true sensitivity and specificity of the antibody ELISA in the absence of reliable, 
independent, diagnostic criteria for toxocariasis. AB a result, the negative/positive 
discrimination level for the Christchurch seroprevalence ELISA was set at the 97.Sth 
percentile of 300 healthy urban blood donors (Clemett et al. 1986). 
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Ideally the sensitivity and specificity of such a test should be invariant over different 
populations, but Lynch et al. (1988a) made the observation that "the seroprevalences 
reported for T. canis infection in some studies have been sufficiently high to raise doubts 
concerning the specificity of the tests used". The result of a serosurvey carried out on 
teenagers in the Caribbean (Bundy et al. 1987) must raise questions about the high level of 
seropositivity shown by the rural Maori children. Bundy's study revealed considerably 
less seropositivity against T. canis (40% to 60%) in an age-related group, despite the high 
levels of environmental contamination (19%) with T. canis ova (Thompson et al. 1986) and 
endemic geohelminthiasis. 
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The measurement of total antibody levels may still only indicate past, perhaps abortive 
exposure to the parasite rather than current infection and potential disease. Because of 
this, the detection of circulating parasite products (ES antigens) would ideally provide a 
complimentary diagnostic method to confinn current infection, especially in those with 
"enigmatic" seropositivity. Antigen-detection assays have proven sensitive for the 
detection of parasite products in other nematode parasitisms in humans (Maizels et al. 
1985; Dissanayake et al. 1984) and other animals (Matsumura et al. 1984; Bowman et al. 
1987a; Robertson et al. 1988). The results of Robertson et al. (1988) and Aguila et al. (1987) 
reporting the presence of ES antigens in human serum samples remain unsubstantialed. 
The aim of this research was to develop such an assay for T. canis infection. The objective 
was to detect circulating ES antigens as a means of establishing current infection, not only 
in suspected clinical cases, but also in apparently healthy seroresponders. It was also 
thought that such as assay could elaborate the nature of the enigmatic seroresponse in 
illness such as Myalgic Encephalomyelitis (M.E.). 
7.1.2 A Comparison of the Three Antigen-Detection Assays 
While the standard curve generated for the Competitive Inhibition ELISA had a level of 
sensitivity similar to that reported by Robertson et al. (1988), the assay was unable to 
detect the presence of ES antigens in the sera tested. A number of factors may have 
contributed to this. 
The addition of more points in the standard curve on the assay between 0 and 20 ng/ml 
may have increased the sensitivity of the assay. Bowman et al. (1987a) reported the 
detection of as little as 1 ng/ml of ES antigens in mouse sera using a polyclonal rabbit IgG 
antibody in a sandwich ELISA. This group routinely EDTA/heat treated their sera which 
consistently allowed them to detect total ES antigens on average an order of magnitude 
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greater than those un-complexed in the circulation. It must be noted however that these 
mice were orally dosed with 500 infective ova, the equivalent of 106 infective larvae in a 70 
kg man, which would represent a considerable larval burden and hence ES output. 
The human sera tested in this study were from people occupationally exposed to dogs. 
Therefore, the high antibody levels may have been more indicative of chronic exposure to 
the parasite rather than active infection. These sera were routinely EDTA/heat treated 
prior to assaying for total ES antigen. If certain epitopes of the circulatory ES antigens are 
heat-labile or antigen is being lost in the process (as was suggested by the result of the 
EDTA/heat treated standard curve in Fig.7) then this .may have further reduced the 
sensitivity of the assay. Bowman's results (Bowman et al.1987a) would suggest that these 
are not contributing factors. 
Standard curves generated in NHS to test the sensitivity of the two monoclonal-based 
antigen capture assays revealed a considerable difference in them (Fig.8). This result was 
later supported by a preliminary investigation of both assays using radiolabelled ES 
antigens. The detection of as little as 20 ng/ml of ES antigens in the two-site/ single step 
assay was similar to that obtained by Robertson et al. (1988) using the same assay 
technique and monoclonal antibody. In contrast, there was no published data on the 
two-site/two step assay employed by the Toxocara Reference Laboratory. It was revealed 
that a positive result for this assay was defined as any serum with an absorbance greater 
than that calculated from the mean plus two standard deviations of 104 normal sera 
assayed by this method. 
This would suggest that many of the sera reported as positive in this study (by the 
standard curve established for the two-site/single step assay) may well fall within an 
acceptable normal range (as determined by the Toxocara Reference Laboratory). In view 
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of this, the diagnostic index advocated by Aguila et al. (1987) may be a more accurate 
indicator of the presence of antigen in the New Zealand sera tested by the two-site/single 
step assay. 
7.1.3 Competing Epitopes in Serum 
A difference was noted in the capacity of the affinity purified rabbit polyclonal antibody 
to bind plate-bound ES antigens when mixed with normal human serum before or after 
EDTA/heat treatment. It was postulated that this was attributable to a heat-labile 
epitope(s) present in the serum, capable of either binding the affinity purified antibody or 
competing with it for binding sites on the plate-bound ES antigens. 
A figure in Robertson's Ph.D. thesis revealed another unpublished and possibly crucial 
detail. Using the two-site assay, it was shown that mice sera had high backgrounds when 
tested for free antigen, before they were infected with T. canis. Subsequent treatment of 
the sera with EDTA/heat removed this background. This implies that the Tcn-2 
monoclonal antibody may be detecting something other than ES antigens in sera. In 
support of this is the unexplained loss of "antigen" in a number of sera from post-partum 
mothers following EDTA/heat treatment. 
Analysis of a few ES antigen positive sera (two-site /single step assay using Tcn-2) with a 
panel of T. canis derived monoclonal antibodies revealed reactivity with the carbohydrate 
directed monoclonals only (Tcn-2 and Tcn-8) and none against the peptide-directed 
monoclonals (Tcn-3 and Tcn-6). 
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Type Periodate Species Binding to ES Molecules 
Sensitivity Specificity Strong Weak 
Tcn-2 IgM + + 70, 120, 400 55 
Tcn-8 IgM + - 70, 120, 400 32, 55 
Tcn-3 IgG1 - - 70, 120 
Tcn-6 IgG1 - - 32 70, 120 
(Maizels et al. 1987a). 
These results all imply that Tcn-2 is able to bind an epitope in serum which is similarly 
glycosylated to the epitope it recognises on the ES antigens. In support of this theory, 
more is becoming known about altered glycosylation in vivo, due to a post-translational 
modification of either a host component or the N-linked oligosaccharides at the CH2 
region of an antibody. These changes have been associated with ageing (Parekh et al. 
1988), chronic inflammatory disease (Parekh et al. 1985; Tomana et al. 1988), and pregnancy 
(Foidart et al. 1986) and have also recently been postulated to arise from damage to IgG by 
free radicals in inflammatory sites (Griffiths & Lunec, 1989). In the case of IgG, a 
glycosylation change could cause it to behave not only as an antibody but also as a 
putative antigen (Hay et al. 1990). 
It is also thought that many parasites and bacteria utilise molecular mimicry to evade host 
defence mechanisms (Smith et al. 1987; Towbin et al. 1987; Galili, 1989; Avila et al. 1989). 
The presentation of evolutionarily conserved human blood group-like antigens on the 
larval surface reduces antigen disparity with the host (Greenblatt et al. 1981; GaWi et al. 
1987; Avila et al. 1988). Because of this, the choice of Tcn-2 as indicator antibody may 
have been unwise. Smith et al. (1983) reported the release of A and B blood group-like 
substances by actively metabolizing L2 larvae. The Tcn-2 monoclonal antibody is also 
known to react with the human A blood group epitope (Kennedy et al. 1987). Blood 
group A-like epitopes have been reported in non-secretor individuals (Dodd, 1968), 
potentially generated during the post-translational processing of protein (Parekh et al. 
1985) or during inflammation (Hay et al. 1990), 
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The absence of clinical disease combined with the presence of enigmatic seropositivity 
and/ or antigen detection in many of the sera examined would seem to support this theory 
of some form of molecular mimicry occurring which may be related to conserved epitopes 
shared between many species of potential paratenic hosts and T. canis L2 larvae. 
7.1.4 Dissociation of Immune Complexes 
Because of the presence of specific antibody in many of the sera examined for antigen, it 
would be logical to expect most of the antigen to be complexed in the circulation, as 
demonstrated by Bowman et al. (1987a). However Robertson only reported levels of un-
complexed antigen in the human sera he tested, despite the high levels of T. canis specific 
IgG antibodies in some of them. 
Three methods to dissociate immune complexes were investigated in this study. The final 
choice, based on the recovery of in vitro produced ES antigen standards from serum, was 
the method using 0.2 M EDTA/heat to treat the samples (Bowman et al. 1987a). 
The apparent inability of the indicator antibody in the Competitive Inhibition ELISA to 
complex the same amount of ES antigens following EDTA/heat treatment of the standards 
suggested that the ES antigens are heat labile. However, a number of studies have 
confirmed the heat stability of the major ES antigens (Meghji & Maizels, 1986; Bowman et 
al. 1987b; Maizels et al. 1987a; Robertson et al. 1988). What may be happening instead is 
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the masking of one or more epitopes recognised by the polyclonal IgG indicator antibody, 
thereby reducing its capacity to complex with the antigen standards. This theory is 
supported by the results gained by EDTA/heat treatment of ES antigens prior to binding 
them to the assay plate, revealed as a slightly reduced ability of indicator antibody to bind 
to the solid phase. 
However, these results may be misleading. ES antigens are known to display a 
particularly heavy and complex level of glycosylation in vitro (Maizels & Selkirk, 1988), 
and yet a T-cell mediated immune response is well documented for T. canis. This implies 
that imrnunogenic peptides are exposed in vivo, prob:ibly by the action of proteolytic 
enzymes which break the ES antigens into smaller glycopeptides. Therefore it has to be 
ascertained if the use of EDTA/heat to dissociate circulating immune complexes also 
results in the reduced recovery of total ES antigens using a polyclonal antisera . Bowman 
et al. (1987a) were able to measure far greater amounts of total circulating ES antigens 
compared to un-complexed ES antigens following EDTA/heat treatment to dissociate 
circulating immune complexes in experimentally infected mice. 
EDTA/heat has also been used to detect complexed ES antigens in the sera of 
experimentally infected animals by the two-site/single step monoclonal antibody assay 
(Robertson et al. 1988). However, nine sera testing positive for un-complexed ES antigens 
in the two-site/ single step assay then tested negative for total ES antigens (by the same 
assay) following EDTA/heat treatment. A discussion with Robertson revealed a similar 
loss in sensitivity in some of his human sera after EDTA/heat treatment, not mentioned in 
the publication arising from this work. Whether this loss of signal was attributable to the 
loss of a heat-labile competitive epitope in the serum, or due to the denaturation of the 
Tcn-2 directed epitope by the heating process is something to be ascertained in the future. 
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7.1.5 Choice of Diagnostic Antibody 
One problem with the monoclonal-based antigen detection assay could be the choice of 
Tcn-2 as the diagnostic antibody. It was originally chosen from a panel of monoclonal 
antibodies because it failed to cross-react with either closely related Ascaroid parasites or 
phosphorylcholine, a common irnrnunogenic determinant in nematodes (Maizels et al. 
1987b). However, it was also reported to react with the human A bloud group epitope 
(Kennedy et al. 1987) and had even been considered for use in blood typing (Smith et al. 
1984b). In retrospect it was a compromise choice that may have been unfortunately 
misleading. 
Tcn-2 has been shown to react most strongly with the 120 kD ES antigen (Maizels & Page, 
1990). This antigen, which appears as a triplet on SDS-PAGE, is one of the most abundant 
larval gene products and there is evidence that it functions as an elastase-like protease, 
effective in tissue penetration (Robertson et al. 1989). The production of large amounts of 
this antigen, which has been shown to have homology with host antigens (Smith et al. 
1984b; Kennedy et al. 1987), suggests the L2 larva could use it as a "smoke-screen" to mask 
antigen epitopes which are more vulnerable to immune attack. 
However, the fact that Tcn-2 is directed against such a well represented epitope makes it 
the ideal antibody to establish the authenticity of an enigmatic seroresponse. This was 
shown very clearly by the inability of the sera from the Maori children to complex with 
the Tcn-2 directed epitope found on ES antigens. This result was unexpected given the 
strong antibody response these children displayed to T. canis ES antigens. However, the 
rural Maori children represent a population with a high incidence of chronic inflammation 
in the liver, caused by hepatitis B (Milne et al. 1985). Another possible contributing factor 
may also be the emergence of endemic giardiasis in some northern areas in New Zealand 
(Okell & Wright, 1990). Lynch et al. (1988a) demonstrated a considerable level of 
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competitive inhibition in sera incubated with Giardia antigens prior to testing for T. canis 
antibodies. 
In the diagnostic assay to detect un-complexed ES antigens, it may be necessary to lose the 
species specificity carried by Tcn-2 for a monoclonal less likely to cross-react with host 
compoi1ents. The peptide-directed monoclonals (Tcn-3 and Tcn-6), which were still able to 
imrnunoprecipitate heat treated (100°C/15 rnins) ES antigens (Maizels et al. 1987a), may 
offer some solution. An ELISA configuration employing both Tcn-2 
(carbohydrate-directed) and Tcn-3 (peptide-directed) monoclonals as coating and top 
antibodies respectively might maintain the specificity of the assay while reducing the 
cross-reactivity. Alternatively, a more thorough evaluation of the Competitive Inhibition 
ELISA, utilizing the affinity-purified rabbit IgG antiserum could be made. 
7.2 Future Directions 
The results of this research project highlight the many areas yet to be explored with this 
parasite. The following section outlines some of the areas I am currently investigating. 
7.2.1 Biological Half-life and Immune Elimination of ES Antigens 
All attempts to develop antigenaemia assays assume that the excretions and secretions of 
T. canis larvae produced in vivo are, at least, antigenically similar to those elaborated in 
vitro. By injecting naive mice with radiolabelled (1125)-ES, it should be possible to monitor 
the length of time the antigens remain in circulation. Imrnunoblotting of the serum from 
these animals, before and after treatment to dissociate immune complexes, will also show 
if the antigenicity and molecular weight of the individual antigen components are 
modified in vivo over time. 
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7.2.2 In vivo Antigen Production 
At present it is assumed, with no evidence to support it, that the level of in vivo ES 
production equates qualitatively and quantitatively to ES production in vitro. Implanting a 
known number of viable larvae (contained in a small, semipermeable capsule) into the 
peritoneal cavity of a mouse will allow an estimation of the amount of antigen that larvae 
can produce in vivo. 
By tolerizing a neonatal mouse to ES antigen prior to implanting the larvae, the 
measurement of circulating antigen levels over time in an un-responsive mouse can te 
compared with levels from a similarly implanted naive mouse. The sera from the naive 
mouse will also provide information about the development of the immune response and 
how quickly antigen is cleared from the circulation. A third, immunized animal will 
indicate how the host and parasite respond during re-challenge. Comparative 
measurement of antigen levels in all three animals may show that immune stimulation 
provokes a protective measure by the larvae, measurable as an increased output of 
antigen. Evidence of this has been recently shown with schistosorniasis (Sher, 1992). A 
fourth mouse, implanted with the tube only, will act as a control. Imrnunoblotting of 
these sera may also give an indication of in vivo antigen modification. 
At the conclusion of the experiment, the animals will be sacrificed in order to determine 
the number of viable larvae remaining. This will provide a measure of larval attrition 
and/ or the effectiveness of the immune response. 
7.2.3 Investigation of Cross-reactivity in the Assays to Date 
The limited availability of Tcn-2, as well as its potential cross-reactivity, make the 
development of a new panel of monoclonal antibodies to T. canis an option worth 
....... ~ .............. __ ~_ ......... ~ ..... -~-- .. 
considering. If the new antibody panel is derived from a hyperun· m · ed th ha 
urns , ra er t n a 
naive animal, the antibody response may be targeted towards epitopes less prone to 
molecular mimicry within the paratenic host (perhaps including man). 
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With sufficient T. canis-specific monoclonal antibody it will be possible to reassess the 
sensitivity of the two-site, sandwich and competitive inhibition ELISAs for detecting 
antigen. This would involve the use of ES antigen to form immune complexes, testing 
sera before and after EDTA/heat, and comparing the monoclonal and polyclonal antibody 
reactivity. Radiolabelling the antigen will give an idea of the proportion able to bind in 
the first two assays. Electrophoresing a range of sera (including those from people with 
chronic inflammation) and immunoblotting with each antibody respectively will determine 
if a pattern of cross-reactivity exists in any particular band of the sera. 
7.2.4 Immunodiagnosis 
The IgG subclass pattern of specific antibodies has been determined for a few chronic 
parasitic infections (Hussain & Ottesen, 1985; Hussain et al. 1987; Lal & Ottesen, 1988; Weil 
et al. 1990; Hagan et al. 1991). It has been found that only IgG4 responses are strongly 
associated with chronic infections (Ottesen et al. 1985). The determination of 
parasite-specific IgG4 levels also gives increased specificity because humans don't respond 
to phosphorylcholine (PC) in the IgG4 subclass (Lal & Ottesen, 1988). Phosphorylcholine 
is an irnmunodominant molecule present on a wide range of organisms and implicated as 
a cause of false positives in serological assays. 
For these reasons, T. canis-specific IgG4 levels may provide a marker between persistent 
and past infection. While recent work has shown different patterns of T. canis antibody 
responsiveness in patients with different clinical characteristics (Taylor et al. 1987; Smith et 
al. 1988; Genchi et al. 1988; Page & Smith, 1988; Mcivor et al.1988), no one has yet 
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examined the IgG subclass response to this parasite. 
Bowman et al. (1987a) were unable to serologically distinguish the presence of ES antigens 
in the sera of mice fed less than 25 infective larvae. This equates to a larval burden of 
50,000 L2s in a 70 kg man. If the production of ES antigens by T. canis in vitro (200 
pg/ day) roughly reflects their production in vivo, this may then preclude the detection of 
light to moderate worm burdens in humans. Ideally, this expanded analysis of the 
antibody isotypes and subclasses will provide an immune profile which can be linked to 
acute or chronic infection. Irnmunodiagnosis will then provide an alternative means of 
diagnosing people with undetectable levels of antigen because of light worm burdens or a 
mature infection where quiescent larvae in granulomas are thought to produce a 
minimum of antigen. 
7.3 Conclusions 
This study was based on two assumptions. The first was that the ES antigens produced 
by T. canis larvae in vivo are the same as those produced in vitro. This is assumed in the 
literature and certainly the immunoreactive pattern of a serum from a clinically diagnosed 
OLM patient appeared identical to that from two different animals immunized with ES 
antigens produced by T. canis L2 larvae in vitro. The second assumption was that because 
of the predominantly T. canis-positive seroresponse in our test sera, any circulating T. canis 
antigen would be bound in immune complexes. 
The initial aim of this study was to detect T. canis specific antigens in human sera, using 
an affinity purified polyclonal antisera. The apparent inability to completely recover in 
vitro produced ES antigens from the standards prepared in sera after EDTA/heat 
treatment, combined with the failure to detect (total) ES antigens in any of the test sera 
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examined, raised doubts about the sensitivity of this method H th h . owever, e apparent eat 
!ability of the in vitro produced ES antigens may be related to ho th t · w ey presen m serum 
to a polyclonal IgG indicator antibody. Future work is planned ·.vhich will investigate this 
possibility more closely (see 7.2.2). 
The publication of two other studies claiming to detect significant amounts of un-
complexed ES antigens in human sera led to the investigation of the monoclonal-based 
antigen detection assays. A considerable disparity was found between the two assays in 
terms of sensitivity, supported by an earlier study which investigated both methods as a 
means of detecting antigen in Bancroftian filariasis. 
Defining serum samples as positive by standard curve may be misleading. A search of 
the literature suggests that establishing the mean for a normal population and calculating 
two standard deviations above this may give a more accurate indication of positivity. 
This is supported by the greatly reduced number of sera testing positive when assessed by 
diagnostic index. 
All three assays evaluated here indicated the presence of an epitope(s) in normal serum 
which can compete in the antigen capture ELISA. The loss of positive signal when some 
sera were EDTA/heat treated prior to the two-site/single step assay suggests that an 
anomaly exists in the current diagnostic assay being used in the UK to detect un-
complexed ES antigens in human sera. Tcn-2, chosen as the diagnostic antibody for this 
assay on the basis of its species specificity, would appear to be less than satisfactory 
because of its ability to cross-react with the human blood group A antigen. It may be 
necessary in this assay to sacrifice the T. canis-specificity endowed by Tcn-2 for a 
diagnostic antibody less likely to cross-react with human components, such as a peptide 
directed monoclonal antibody or an affinity-purified polyclonal antibody. 
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A further investigation of the unexpected inability of the Maori childrens' sera to complex 
the Tcn-2 directed epitope on ES antigens is warranted when more monoclonal antibody 
b~comes available. It will be interesting to see if sera from the post-partum mothers and 
M.E. patients also show a similar result. 
It must be remembered however that even if a reliable assay procedure is established for 
the detection of ES antigens in human sera, the level of sensitivity attainable in the assay 
is critical. The use of an assay based on detecting circulating antigens may lack the 
sensitivity required to detect current infection in those people with either a low larval 
burden or a mature infection where quiescent larvae in granulomas are thought to 
produce a minimum of antigen. With these people, the establishment of a pattern of 
immune humoral reactivity (immunodiagnosis) may provide an alternative approach to 
distinguish those immunoprotected individuals (seropositive) from those with clinical 
disease. This differs from the current ELISA for seropositivity which measures the 
combined total IgM/lgG response against ES antigens (Clemett et al. 1985). 
The fulfilment of the objectives outlined above, whether they be antigen detection or 
immunodiagnosis, should provide the necessary definitive assessment of seropositivity. 
This will in tum lead to a greater understanding of the pathology and spread of this 
endemic parasitic disease. If the high current seropositivities do reflect disease, then the 
results may prove that infection with this parasite is responsible for much hidden 
low-grade ill health within our communities. 
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APPENDICES 
Appendix i 
Parasite Maintenance 
(a) Isolation and Embryonation of T. canis Eggs 
1. T. canis worms were collected from the faeces of antihelminthic purged dogs 
and transported to the laboratory in formalin. 
2. Adult femalE~ worms .were separated and washed with water prior to dissecting 
out the tennmal portion of their reproductive tracts. 
3. Uteri con.taining eggs ~ere pla~ed in a glass petri dish containing water and 
the eggs isolated. Utenne debris was removed fastidiously and the egg clumps 
repeatedly passed gently through a pasteur pipette to de-aggregate them. 
4. The presence of viable eggs was confirmed microscopically (those eggs having 
a thick pitted coat and perivitelline space). 
5. The pooled eggs were repeatedly washed (100g, 3 min.) to remove immature 
eggs, sperm and any remaining debris. Initial washes were in water (x3); 
subsequent washes were in 0.1 N H2S04 (x3) . 
6. Eggs were embryonated to infectivity in 0.1 N H2S04' 1 cm deep in a glass 
petri dish for 3-4 weeks at room temperature. To promote air exchange, the lid 
was removed and the dish gently swirled for 30 seconds each day. 
Embryonation was monitored microscopically in the latter stages to enable the 
process to be stopped when the larvae in the eggs became motile, but before 
they became coiled in a uniform spiral. 
7. Infective eggs could then either be artificially hatched or stored at 4°C until 
required. 
(b) Artificial Hatching of eggs (Maizels et al. 1984). 
1. 
2. 
3. 
Infective eggs were repeatedly washed in deionized water before being de-
coated with a commercial bleach solution (Janola) containing 3.7% 
hypochlorite. De-coating was allowed to proceed until microscopic . . 
examination ascertained that the larvae were surrounded by the flexible inner 
ascaroid membrane only. 
Repeated washing of the de-coated eggs in deionized water removed all traces 
of hypochlorite. 
The eggs were then re-suspended in water to give a concentration of ~.5-1.0% 
(v /v) and allowed to equilibrate at 37°C. Hatching was induced at this 
temperature by the bubbling of a mixture of 5% COi-95% N2 through the egg 
suspension for 30 to 60 minutes. 
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(c) Recovery of infective second-stage (L2) larvae (de Savigny, 1975). 
1. Hatched larvae were repeatedly washed in phosphate buffered saline (pH 7.~) 
to remove any of the enzymes associated with hatching. 
2. The larvae were then applied as a thick slurry to the top chamber of a 
Baermann apparatus, designed to separate motile larvae from hatching debris. 
Baermannization was at 37°C for 1-8 hours or overnight (as required). 
3. Collected worms were repeatedly washed L'1 PBS and culture media before 
being suspended to 6000/rnl (5 ml per flask) for culture at 37°C in a 53 C02 
atmosphere. (Culture media used was RPMI 1640 containing 25 rnM HEPES, 
100 IU/ml penicillin, 100 ug/rnl streptomycin, 0.23 glucose and 2 g/l 
NaHC03). 
(d) Recovery of ES Antigens 
1. At weekly intervals the cultures were examined for viability (> 95% 
acceptable). 
2. The culture medium was collected from each flask and replaced (aseptically) 
with fresh medium and the culture re-gassed with 5% C02 prior to re-
incubation. The conditioned medium was filtered (0.2 u) to exclude any larval 
contamination and stored frozen. Prior to use it was dialysed extensively 
against 0.05 M ammonium bicarbonate and concentrated by ultrafiltration 
(Millipore immersible CX-10). 
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Appendix ii 
Sodium Dodecyl Sulph<.ce - Polyacrylamide Gel Electropho · (SOS 
1970). res1s -PAGE) (Laemmli, 
Reagents: 
1. 
2. 
3. 
4. 
5. 
6. 
Acrylamide, bis-acrylamide, SOS and TEMEO (N N N' N'-t t h l · . 
all electrophoresis purity reagents (Bio-Rad) ' ' ' e ramet Y enediamme) -
Tris (=Tris-(hydroxyrnethyl)-methylamine) - Sigma 
Glycerol - AnalaR, BDH 
Ammonium persulphate - AnalaR, BOH 
Sucrose - Fisher, ACS 
Molecular Weight Markers - Amersham 
Solutions: 
1. Acrylamide Stock: 30% (w /v) acrylamide, 0.8% (w /v) bis-acrylamide in deionized 
water, millipore filtered (0.45 urn) and stored at 4°C. 
2. Running Gel Buffer: 1.5 mol/l Tris-HCl, 0.4% (w / v) SOS (pH 8.8) 
3. Stacking Gel Buffer: 0.5 mol/l Tris-HCl, 0.4% (w /v) SOS (pH 6.5) 
4. Reservoir Buffer: 0.025 mol/l Tris, 0.192 mol/l glycine, 0.1% (w/v) SOS (pH 8.3) 
5. Polymerizing agents: TEMED, 10% (w /v) ammonium persulphate (freshly prepared) 
Gel Apparatus: 
Pharmacia Mini-Gel System, consisting of 1.5 mm plastic spacers along the sides to 
separate two 80 cm2 glass plates. Linear gradient gels were poured from the bottom 
of a multiple castng chamber (Pharmacia Four Gel Casting Stand) through an inlet 
port on the front panel. 
A gradient maker, consisting of a reservoir chamber and a mixing chamber and sited 
on a magnetic stirrer, was used to premix the solutions. Polymerizing agents were 
added at this point each solution. A peristaltic pump, connected between the 
gradient maker and the casting chamber, ensured continuous delivery of the 
solutions. 
Gel Mixtures: 
(to pour 4 gels) 
5% acrylamide mixture 
3.0 ml stock acrylamide 
4.5 ml stock running gel buffer 
10.5 ml deionized water 
12 ul TEMED 
48 ul ammonium persulphate 
20% acrylamide mixture 
11.8 ml stock acrylamide 
4.5 ml stock running gel buffer 
1.6 ml deionized water 
12 ul TEMED 
24 ul ammonium persulphate 
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To ensure a flat surface and prevent oxygen from inhibiting gel polymerization the 
resolving gel was overlaid with water. The gel was left at least one hour before pouring a 
3.33 acrylamide stacking gel and inserting a 10 well sample comb 
(25 ul maximum sample volume). 
After polymerization of the stacking gel (45 minutes) the comb was removed and the gel 
was ready for use. The gel was positioned in the Pharmacia Midget Electrophoresis Unit 
containing reservoir buffer (0.025 mol/l Tris, 0.19 mol/l glycine, 0.1 % (w /v) SDS, pH 8.5). 
Samples were applied and electrophoresed for 90 minutes at 200 volts (maximum), 40mA 
current and 35 watts. 
Sample Preparation: 
Aliquots of ES antigens (previously assayed for protein) were prepared for SOS-PAGE by 
adding an equal volume of SDS sample buffer and heating at 100°C for 3 minutes. The 
molecular weight markers were also prepared this way. 
SOS Sample Buffer: 0.125 mol/l Tris-HCl (pH 6.5) 
2% (w/v) SDS 
10% glycerol 
0.001 % (w /v) bromophenol blue 
Appendix iii 
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Silver Staining (Morrisey, 1981) 
Reagents: 
1. Methanol (drum grade) 
2. Acetic acid (drum grade) 
3. Dithiotreitol (Sigma grade) 
4. Silver nitrate (AnalaR, BDH) 
5. 37% commercial formaldehyde 
6. Citric acid (AnalaR, BDH) 
7. Sodium carbonate (AnalaR, H&W) 
Solutions: 
1. Fixative 1 : 50% Methanol/10% acetic acid 
2. Fixative 2 : 5% methanol/7% acetic acid 
3. Dithiothreitol : 0.5mg% 
4. Stain : 0.1 % silver nitrate 
5. Developer: 3% sodium carbonate (plus SOul forrnalin/100rnls) 
6. Stop staining: 2.3 mol/l citric acid 
(All solutions made with deionized water & Millipore filtered) . 
Procedure: 
1. The place was placed in Fixative 1 for 30 minutes; followed by Fixative 2 for another 
30 minutes . 
2. It was then rinsed in water over 2 hours (with frequent changes) or overnight. 
3. The gel was placed into dithiothreitol for 30 minutes, which was then poured off. 
4. The stain added for 30 minutes, then also poured off. 
5. The gel was rinsed rapidly once with water, then twice with developer, prior to 
soaking in the remainder of the developer until the desired level of staining was 
achieved. 
6. Staining was stopped by the addition of citric acid directly into the developer (until 
pH 7.0 was reached). The gel was then agitated for 10 minutes, followed by 
washing several times over 30 minutes in water. 
(The gel was in a covered dish and gently agitated during all stages). 
Appendix iv 
Farmer's Reducer (Huekeshoven & Demick, 1985). 
Reagents: 
0.3 g potassium ferricyanide 
0.6 g sodium thiosulphate 
0.1 g sodium carbonate 
Made up to 200 ml with d.H
2
0 
Procedure: 
1. The gel was washed and silver stained prior to being treated. 
2. It was placed into the Farmer's reducer for 10-30 seconds, until the background 
staining had reduced sufficiently to maximise the staining of bands. 
3. The Farmer's reducer was rapidly decanted and the gel washed under running tap 
water. 
4. After two washes with deionized water, the gel was restained if necessary, starting 
with the silver nitrate solution. 
80 
Appendix v 
Transfer & Immunoblotting of Proteins 
a) Transfer of Proteins to Nitrocellulose 
1. The resolving gel was equilibrated in transfer buffer for 30 minutes prior to 
assembling the blot. 
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2. The blot was assembled by first cutting filter papers and NC membrane to same size 
as the gel to be transferred. 
3. The anode plate of the semi-dry blotting apparatus (Novablot Electrophoresis 
Transfer Kit, Pharmacia) was saturated with d.H20 and excess removed before a total 
of nine soaked filter papers were carefully placed in a pile on the horizontal surface. 
4. This was first overlaid with the wetted membrane, followed by the resolving gel and 
then nine more soaked filter papers. 
(At each addition in Steps 3 & 4 extreme care was taken to avoid air bubbles). 
5. The cathode electrode plate was saturated with d.H20, excess removed, and the plate 
put in place over the anode. 
6. The two were connected together, the lid closed and the blot run. 
Transfer Buffer: 
0.303 g Tris 
1.441 g Glycine 
0.02% (w /v) SOS 
10% Methanol 
in 100 mls d.H20 
Conditions for Blotting to Nitrocellulose: 
The size of the blot (in cm2) was calculated and multiplied by SmA to give the amount of 
power required for blotting over a 30 minute period. 
b) lmmunoblotting 
Reagents: 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
Tris-buffered saline (TBS) 
Tris-buffered saline with 0.05% Tween 20 (TTBS) 
Fetal calf serum (FCS) 
Primary antibody directed against ES antigens . t'b d 
' d · t nmary an 1 o y HRP-conjugated secondary antibody, directe agams ~ ) 
Horseradish peroxidase colour development reagent (Bio-Rad 
Methanol (BDH, HPLC-grade) 
30% (w /v) H202 (ice-cold) 
Procedure: 82 
1. Following transfer, th~ blot was washed in TBS for 30 minutes at 37°C, followed by 
5% FCS/TBS for 30 nunutes to block nonspecific binding sites. 
2. This was followed by washing with 0.05% tween/TBS (TTBS) for 10 minutes. (The 
blot could be stored in TBS at 4°C if necessary at this stage). 
3. The lanes were marked and cut with a scape! to allow individual probing of the 
resolved antigens by several immune sera. 
4. Each strip was incubated with a primary antibody (diluted 1 /200 in 5% FCS/TBS) 
for 2 hours (on a rocker) at room temperature. 
s. All strip were washed three times (5 mins each) in TBS, TTBS, TBS. 
6. Each strip was then incubated in a species-specific second antibody 
(HRP-conjugated) and incubated 1.5 hours (on a rocker) at room temperature. 
7. After three more washes (as in step 6), each strip was developed with 0.03g HRP 
colour development reagent, dissolved in 10 ml methanol, 40 mls TBS and 15 ul 30% 
H202. 
8. The staining reaction was stopped by washing the strips in d.H
2
0. 
Appendix vi 
Isolation of IgG 
Reagents: 
1. Polyclonal rabbit anti-ES antiserum 
2. DEAE (diethylaminoethyl-) AFFI-GEL Blue gel (Bio-Rad), equilibrated in following 
buffer in a 22 cm column. 
3. Buffer for rabbit IgG purification: 0.02 M Tris-HCl (pH 8.0), 0.028 M NaCl, 0.023 
NaN3. 
Procedure: 
1. Rabbit-antiserum was dialysed at 4°C against the buffer. 
2. Dialysed serum was applied to the equilibrated column. 
3. IgG was eluted with three bed volumes of the buffer and the eluate monitored by 
absorbance at 280 nm. 
4. Fractions corresponding to the protein peak were pooled. 
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Appendix vii 
Affinity Purification of Antibody 
Reagents: 
1. Nitrocellulose paper 
2. Small, disposable plastic column (3 cm x 0.4 cm) 
3. 2.5 mg ES antigen (in PBS) 
4. 5% normal rabbit serum (in PBS) 
5. rabb.t anti-ES antiserum (IgG fraction) - 1 mg/ml 
6. 3M ammonium thiocyanate 
Procedure: 
1. Approx. 100 cm
2 
nitrocellulose was cut into small squares and homogenised gently 
in PBS. 
2. Fines were decanted from coarse particles by repeated washing in PBS prior to 
packing the column. 
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3. ES antigens was applied to the column over a 5 day period. The amount bound (1.9 
mg) was determined by spectrophotometric analysis (A280) of the eluent collected 
from the column. 
4. The column was washed continuously over a 24 hour period with 5% normal rabbit 
serum to block remaining binding sites. 
5. Before use, the column was washed four times with PBS, followed by two 
ammonium thiocyanate washes, then another three PBS washes. (Each wash 
consisted of a 5 ml volume). 
6. 25 mls of 1:10 diluted antiserum (in PBS) was passed through the column at a rate of 
0.5 ml/min. 
7. After 5 more PBS washes, the bound antibody was eluted by passing 5 ml of 3 M 
ammonium thiocyanate through the column and collecting the eluent. 
8. The affinity purified antibody was dialysed against PBS for 20 hours. 
9. Total recovery was assessed by protein concentration and antibody reactivity was 
determined by indirect ELISA. 
Appendix viii 
To Remove Antibodies Specific For Blood Group Activity 
1. Human AB+ve red blood cells (RBC) were spun at 4°C (1500 rpm/10 minutes) to 
give 8ml packed RBC. 
2. The packed cells were then washed three times with PBS. 
3. Affinity-purified rabbit anti-ES antiserum was then added to the washed RBC and 
incubated for 30 minutes at room temperature (with occaisional mixing). 
4. Following centrifugation, the supernatant was removed and the optimal dilution of 
the antisera then determined by indirect ELISA against ES antigens. 
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Appendix ix 
Sandwich ELISA 
This ELISA technique is an accepted method for antigen capture. 
The principle is to use antibody bound to the solid phase (irnrnunoassa lat ) t 
specifically capture the antigen being measured. Y P e 0 
Reagents: 
l. Polyclonal sheep anti-ES antiserum (0.D.495 = 1.450) 
2. Affinity purified rabbit anti-ES antiserum (0.D.495 = 1.340) 
3. Washing solution: PBS-0.053 Tween-20(PBS-T). 
4. Diluent and blocking solution: 53 fetal calf serum (FCS)in PBS-T. 
5. HRP-conjugated goat anti-rabbit antibody (IgG). 
6. OPD chromogen and hydrogen peroxide substrate. 
7. Nunc immunoassay plate (96 well) . 
Procedure: 
1. The immunoassay plate was coated with sheep anti-ES antiserum (diluted in PBS) to 
give a concentration of 2 ug/ml, and incubated overnight at 4°C. 
2. Following washing three times with PBS-T, the plate was blocked for 2 hours with 
53 FCS/PBS-T. 
3. ES antigen standards (prepared in diluent) were added to the wells and the plate 
incubated for one hour at room temperature, then washed as above. 
4. Affinity purified rabbit anti-ES (1:100) was then added, and incubated, followed by 
washing (as above). 
5. To visualise bound rabbit antibody, goat anti-rabbit IgG (1:5000) was added and 
incubated as above. 
6. Following three more washes, OPD chromogen and hydrogen peroxide ~ubstrate 
were used to develop the plate, which was then read spectrophotometncally at 
495nm. 
Appendix x 
Competitive Inhibition ELISA 
The assay is based on the principle that antigens in the test sample will f · 
1 h · b d . orrn unrnune comp exes w en premcu ate with the appropriate indicator antisera thereb 
proportionally reducing the level of antibodies subsequently free to bind to a~ antigen 
coated plate. The procedure was adapted from as assay designed to measure secreted 
mucins (Mantle & Thakone, 1988). 
Reagents: 
1. ES antigens for coating plates: 1ug/ml in PBS. 
2. Washing solution: PBS-0.05% Tween-20(PBS-T). 
3. Diluent and blocking solution: 5% fetal calf serum (FCS)in PBS-T. 
4. Affinity purified rabbit anti-ES antisera, optimal dilution 1:100 (0.D.
495
:1.340). 
5. HRP-conjugated goat anti-rabbit antibody (IgG). 
6. OPD chromogen and hydrogen peroxide substrate. 
7. Nunc immunoassay plate (96 well). 
Procedure: 
1. The irnrnunassay plate was coated ES antigens in PBS (1 ug/ml) and incubated 
overnight at 4°C. 
2. In a separate plate 75 ul of test serum, diluted 1:5 in diluent (final concentration 
1:10), was incubated with 75 ul of affinity purified rabbit anti-ES antisera (diluted 
1:100) overnight at 37°C. 
3. ES antigen coated plate was washed three times with PBS-T to remove unbound 
antigen and samples of serum plus rabbit indicator antisera were transferred to the 
plate and incubated for 90 minutes at 37°C. 
4. Unbound material was removed by washing three times with PBS-T, then goat 
anti-rabbit IgG (1:5000 in diluent) was added and incubated as above. 
5. Following three more washes, OPD chromogen and hydrogen peroxide. substrate 
were used to develop the plate, which was then read spectrophotometncally at 
495nm. 
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Appendix xi 
Two Site/ Single Step ELISA 
This proceedur~ was specifically designed for the detection of circul::\ting ES antigen in 
infected sera using the monoclonal antibody Tcn-2 (Robertson et al. 1988). 
Reagents: 
1. Coating buffer: 0.06 M carbonate buffer, pH 9.6 
2. Diluent and washing solution: PBS-0.05% Tween-20(PBS-T). 
3. Monoclonal antibodies: 
(a) for coating plates : 5 ug/mL of purified Tcn-2 in coating buffer. 
(b) HRP-conjugated Tcn-2. Optimal dilution determined by titration and 
found to be 1:4000. 
4. ABTS substrate (manufactured by Kirkegaard & Perry). 
5. Nunc immunoassay plate (96 well). 
Proceedure: 
1. Plates were coated with monoclonal antibody by adding 50ul to each well and 
incubating covered plates overnight at 4°C. 
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2. In a separate plate 25 ul of test serum, diluted 1:5 in PBS (final concentration 1:10), 
was incubated with 25 ul of HRP-Tcn-2 diluted at 1:2000 in PBS (final concentration 
1 :4000) for 2 hours at 37°C. 
3. Tcn-2 coated plates were washed three times with PBS-T to remove unbound 
antibody and samples of serum plus HRP-Tcn-2 transferred to the plate and 
incubated overnight at room temperature. 
4. Unbound material was removed by washing three times with PBS-T. 
5. Plates were then developed with ABTS (200 ul/well) and read 
spectrophotometrically at 405nm. 
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Appendix xii 
Two Site/ Two Step ELISA 
This proceedure is a modification of the two site/ single step ELISA (Appendix xi) and is 
routinely used to detect ES antigens in sera at the UK Toxocara Reference Laboratory 
(Gillespie, Personal Communication). 
Reagents: 
As described in Appendix xi, plus 5% fetal calf serum (FCS) as ablocking agent. 
Procedure: 
1. 
2. 
3. 
4. 
5. 
6. 
Plates were coated with monoclonal antibody as described (Appendix xi). 
Unbound material was removed by washing, followed by blocking the plate to 
prevent any nonspecific binding (5% FCS in PBS-T for one hour at room 
temperature). 
Serum samples (diluted 1:10 in 5%FCS/PBS-T) were added to Tcn-2 coated plate and 
incubated for one hour at 37°C. 
Following washing three times with PBS-T, HRP-Tcn-2 (diluted 1 :4000 in 
5%FCS/PBS-T) was added and incubated for one hour at 37°C. 
Unbound material was removed by washing three times with PBS-T. 
Plates were developed with ABTS (200 ul/well) and read spectrophotometrically at 
405nm. 
: 
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Results of sera testing positive for ES Antigens by the two-site/single step ELISA. 
Group Patient No. O.D.s04 Diagnostic Index 
Post-partum 55 0.112 
Mothers 58 0.101 
(n=55) 59 0.156 
65 0.106 
68 0.123 
69 0.120 
74 0.178 3.1 
75 0.123 
M.E.Patients 11 0.209 3.5 
(n=78) 26 0.161 
30 0.573 9.7 
34 0.114 
45 0.377 6.4 
47 0.186 3.2 
53 0.205 3.5 
55 0.557 9.8 
58 0.111 
69 0.400 6.8 
71 0.177 3.0 
78 0.199 3.4 
82 0.143 
Hydatid Control 151 (1986) 0.100 
Officers 32 (1987) 0.106 
(n=43) 
Maori Children 15 0.228 3.5 
(n=538) 19 0.101 
21 0.146 
22 0.116 
26 0.176 
28 0.110 
34 0.140 
42 0.106 
51 0.194 3.0 
55 0.261 4.0 
56 0.112 
58 0.102 
59 0.106 
63 0.383 5.8 
67 0.294 4.5 
68 0.108 
72 0.169 
75 0.105 
76 0.116 
5.6 80 0.370 
: 
91 81 0.100 
83 0.111 
87 0.124 
97 0.159 
98 0.108 
108 0.802 12.1 109 0.198 3.0 111 0.240 3.6 112 0.161 
113 0.322 4.9 114 0.107 
115 0.401 6.1 116 0.375 5.7 120 0.243 3.7 
121 0.810 12.3 
122 0.107 
123 0.163 
124 0.105 
125 0.139 
128 0.154 
130 0.433 6.6 
131 0.902 13.7 
132 0.244 3.7 
135 0.104 
137 0.166 
139 0.320 4.8 
142 0.108 
144 0.267 4.0 
145 0.110 
146 0.160 
147 0.234 3.5 
153 0.180 
154 0.520 7.9 
160 0.381 5.8 
161 0.106 
162 0.401 6.1 
166 0.120 
169 0.188 
173 0.177 
174 0.243 3.7 
179 0.123 
181 0.141 
183 0.120 
184 0.163 
188 0.151 
191 0.108 
192 0.129 
201 0.138 
203 0.115 
205 0.115 
206 0.229 3.5 
216 1.398 21.2 
220 0.140 
226 0.225 3.4 
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227 0.489 7.4 
239 0.135 
240 0.104 
242 0.106 
249 0.144 
255 0.154 
260 0.103 
261 0.137 
270 0.169 
276 0.134 
279 0.150 
293 0.121 
303 0.304 4.6 
304 0.440 6.7 
305 0.126 
306 0.187 
306 0.225 3.4 
308 0.264 4.0 
310 0.565 8.6 
311 0.361 5.5 
312 0.127 
313 0.100 
314 0.137 
315 0.116 
317 0.104 
318 0.128 
319 0.528 8.0 
323 0.102 
329 0.469 7.1 
330 0.113 
332 0.114 
333 0.109 
340 0.198 3.0 
341 0.151 
347 0.153 
345 0.121 
354 0.134 
358 0.292 4.4 
359 0.163 
360 0.106 
361 0.402 6.1 
365 0.106 
370 0.241 3.7 
380 0.103 
381 0.125 
385 0.147 
484 0.141 
486 0.112 
488 0.121 
492 0.195 3.0 
500 0.118 
508 0.129 
515 0.257 3.9 
517 0.150 
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520 0.147 
522 0.372 5.6 
523 0.103 
524 0.261 4.0 
525 0.185 
526 0.293 4.4 
531 0.107 
533 0.143 
539 0.587 8.9 
543 0.108 
548 0.419 6.3 
554 0.417 6.3 
557 0.246 3.7 
559 0.155 
566 0.154 
573 0.359 5.4 
575 0.190 
576 0.202 3.1 
581 0.126 
582 0.453 6.9 
584 0.308 4.7 
591 0.125 
593 0.579 8.8 
595 0.261 4.0 
596 0.137 
607 0.241 3.2 
639 0.245 3.7 
640 0.161 
643 0.112 
665 0.145 
666 0.101 
667 0.185 
687 0.418 6.3 
703 0.348 5.3 
715 0.210 3.2 
724 0.123 
725 0.132 
727 0.128 
735 0.353 5.3 
736 0.183 
747 0.114 
751 0.103 
760 0.112 
973 0.106 
974 0.223 3.4 
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Comparison of results of the two monoclonal-directed antigen detection assays 
Group Patient No. Two-site/single step Two-site/two step 
Post-partum 15 0.058 0.051 
Mothers 18 0.060 0.055 
25 0.098 0.049 
28 0.074 0.053 
63 0.066 0.059 
65 0.106 0.060 
68 0.123 0.059 
69 0.120 0.053 
71 0.088 0.065 
74 0.178 0.164 
75 0.123 0.053 
76 0.069 0.097 
M.E.Patients 3 0.063 0.069 
26 0.161 0.054 
30 0.573 0.063 
34 0.114 0.067 
45 0.397 0.066 
53 0.205 0.087 
55 0.557 0.060 
58 0.111 0.054 
61 0.061 0.064 
65 0.059 0.065 
69 0.400 0.063 
71 0.177 0.049 
78 0.199 0.064 
82 0.143 0.063 
Maori Children 9 0.069 0.072 
18 0.064 0.055 
31 0.090 0.068 
33 0.065 0.075 
67 0.294 0.089 
201 0.138 0.065 
206 0.229 0.058 
270 0.169 0.056 
279 0.150 0.061 
295 0.094 0.058 
296 0.076 0.084 
299 0.071 0.066 
300 0.077 0.058 
306 0.225 0.056 
0.064 309 0.075 
0.067 310 0.565 
0.573 312 0.127 
0.055 316 0.068 
0.056 317 0.104 
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322 0.071 0.061 
324 0.067 0.068 
325 0.083 0.055 
327 0.086 0.087 
330 0.113 0.061 
332 0.114 0.059 
334 0.071 0.054 
341 0.151 0.054 
346 0.075 0.057 
349 0.099 0.062 
357 0.093 0.059 
359 0.163 0.053 
369 0.077 0.056 
372 0.060 0.056 
375 0.097 0.061 
378 0.099 0.064 
380 0.103 0.064 
383 0.065 0.054 
384 0.070 0.061 
500 0.118 0.053 
508 0.129 0.046 
511 0.063 0.052 
520 0.147 0.059 
522 0.372 0.057 
524 0.261 0.422 
527 0.063 0.079 
554 0.417 0.047 
561 0.064 0.065 
573 0.359 0.052 
576 0.202 0.055 
581 0.246 0.058 
